rfhg_205774.1

Basic information about the TSS

---

TSS ID: rfhg_205774.1 Species: human Chr: chr19		Start: 3062278 End: 3062377 Strand: -
Source datasets	DRA013844|PRJNA401781|PRJNA615891|PRJNA4843412
Protocol	CAGE|SLIC_CAGE|NETCAGE
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK314713:0 GeneID: 166 HGNC/MGI_ID: HGNC:307 UniProt_ID: Nearer transcript ids and distances: ENST00000585782.1:1 AF072902:2 ENST00000585557.1:-33 ENST00000586003.1:44 U04241:49 X73357:84 ENST00000592330.5:88 ENST00000327141.9:-118 NM_001130.6:-118 NM_198970.2:-118 view more...

Gene_name: TLE family member 5, transcriptional modulator Gene_symbol: TLE5 Gene_synonyms: GRG5 Gene_source: HGNC:307

TATA-Box annotation

---

Distance to TSS:	168
Nearest PromoterID:	NM_001130
Entrez ID:	166
Nearest Unigene:	Hs.515053
Nearest Refseq:	NM_001130
Nearest Ensembl:	ENSG00000104964
Gene Name:	TLE family member 5, transcriptional modulator
Gene Alias:	AES|AES-1|AES-2|ESP1|GRG|GRG5|Grg-5
Gene Type:	protein-coding
CpG%:	0.191919
GC%:	0.860000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TLE5 p2@TLE5 p3@TLE5 p4@TLE5 p5@TLE5 p6@TLE5 p7@TLE5 p8@TLE5 p9@TLE5 p10@TLE5
Sample		p1@TLE5	p2@TLE5	p3@TLE5	p4@TLE5	p5@TLE5	p6@TLE5	p7@TLE5	p8@TLE5	p9@TLE5	p10@TLE5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	34.29	2.53	1.36	1.56	0.00	0.19	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	49.37	4.25	1.82	1.21	0.00	0.20	1.01	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	50.35	4.44	1.16	1.74	0.00	0.96	0.77	0.00	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	36.59	3.95	0.83	0.62	0.21	0.21	0.42	0.21	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	46.79	4.50	1.12	1.12	0.00	0.22	0.67	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	41.09	2.13	0.39	0.58	0.00	0.39	0.00	0.19	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	42.71	4.14	1.74	2.18	0.22	0.44	0.22	0.00	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	43.36	3.88	0.73	1.45	0.00	0.24	0.48	0.00	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	43.38	7.05	1.07	1.50	0.21	0.21	0.21	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	33.04	1.74	1.16	0.00	0.00	0.58	0.00	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	32.34	3.64	0.40	0.81	0.00	0.00	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	38.62	2.44	0.41	0.00	0.00	0.41	0.41	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	174.57	46.42	9.51	1.29	1.45	1.61	0.64	3.55	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	138.47	32.48	7.22	1.95	1.20	1.80	1.20	3.91	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	142.05	43.03	9.66	2.42	1.98	0.44	0.88	2.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	140.08	42.00	8.80	1.76	1.51	1.26	1.26	2.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	131.70	34.07	5.90	1.53	1.31	1.09	1.53	1.97	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	134.56	25.73	3.37	1.27	1.69	0.42	1.69	2.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	116.23	13.86	1.07	5.86	0.53	1.60	1.07	4.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	164.28	36.41	8.88	2.26	1.05	1.65	1.05	2.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	147.28	35.95	6.82	2.41	1.47	1.20	1.87	2.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	153.98	28.14	7.08	2.93	1.21	0.86	1.38	3.97	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	121.63	31.28	6.72	1.68	0.65	0.65	1.42	3.10	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	136.38	31.79	8.74	1.70	0.73	0.97	0.00	2.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	145.25	40.25	9.03	2.58	1.03	1.03	2.06	2.84	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	167.75	22.79	8.23	2.22	0.32	1.90	1.27	4.43	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	131.32	20.33	2.20	1.10	0.55	0.00	0.00	0.55	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	152.06	38.19	10.84	1.41	0.94	0.71	1.41	4.01	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	157.81	32.63	8.08	1.94	0.97	0.97	0.81	2.26	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	143.69	43.25	11.04	2.17	0.72	1.09	1.09	3.08	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	129.17	33.70	8.16	0.63	0.63	1.67	0.63	2.51	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	132.66	39.27	7.23	1.17	0.39	1.37	0.78	2.54	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	124.72	25.75	7.17	1.48	1.06	0.84	0.84	3.17	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	100.45	12.87	2.64	2.47	0.00	0.66	1.15	2.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	145.48	37.96	9.72	1.87	1.31	1.50	0.37	2.43	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	138.16	46.76	11.69	1.34	2.11	1.15	1.15	3.83	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	154.10	44.55	11.85	2.25	1.23	0.61	1.43	2.45	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	106.18	36.67	10.07	1.41	1.01	1.41	0.20	4.03	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	135.32	42.14	9.18	1.89	2.43	0.81	1.08	1.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	121.23	34.09	11.28	1.20	1.92	1.20	0.72	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	121.86	37.64	9.41	0.71	0.47	0.71	0.00	2.82	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	118.87	16.40	4.68	1.17	0.88	0.73	0.88	1.76	0.15	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	130.96	45.97	15.61	2.11	1.27	1.05	1.48	4.64	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	151.23	42.31	11.36	1.05	1.57	1.40	0.52	3.15	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	127.49	50.19	12.05	1.61	1.81	2.21	1.20	2.81	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	162.62	41.64	8.61	1.63	0.47	0.93	1.63	1.40	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	140.82	45.10	12.72	1.44	0.96	1.92	0.72	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	151.71	43.81	11.92	2.09	1.79	1.19	0.30	4.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	136.44	42.37	10.05	0.96	1.44	1.20	0.00	2.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	148.21	37.81	6.87	2.43	1.01	0.61	1.21	3.64	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	127.48	30.33	6.56	1.23	0.41	0.82	1.84	1.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	157.66	39.36	8.89	3.11	0.89	1.78	1.33	1.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	0.00	0.00	0.00	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	69.20	47.55	8.16	1.77	0.71	1.42	1.77	1.77	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	78.21	50.37	9.28	1.33	1.33	0.66	1.33	1.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	40.27	6.71	1.68	0.00	0.00	0.00	3.36	2.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	103.33	12.40	2.76	1.84	0.00	1.38	1.84	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	70.98	66.12	11.02	0.65	0.32	0.65	1.30	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	54.60	74.51	9.64	0.64	1.93	2.25	0.64	1.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	132.96	26.09	5.34	2.20	0.00	0.63	0.94	0.94	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	57.81	66.98	7.76	0.00	0.00	1.41	3.53	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	62.81	51.59	7.85	1.68	1.68	1.12	0.56	0.56	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	90.76	27.07	3.98	1.59	0.00	0.00	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	139.30	27.52	5.44	1.36	0.68	0.00	1.70	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	64.66	101.38	18.20	2.60	1.30	0.65	0.65	2.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	90.52	103.65	15.62	2.13	0.00	0.35	2.84	1.77	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	7.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	62.89	98.48	7.80	4.39	2.93	0.49	2.44	3.41	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	77.36	102.15	8.43	2.48	0.99	0.50	1.98	1.98	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	79.75	99.45	10.79	2.81	1.41	0.47	1.41	3.28	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	123.53	64.25	6.29	8.61	0.99	0.00	1.66	1.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	65.27	134.56	8.97	4.02	1.24	0.31	3.09	3.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	74.30	127.50	11.62	0.92	1.22	0.92	1.83	4.28	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	130.51	33.89	8.71	7.13	4.28	4.59	3.01	2.53	0.95	1.11
Adipocyte - breast, donor2	11327-117E4	119.20	38.82	7.06	13.48	3.05	6.26	5.29	1.44	0.48	0.96
Adipocyte - omental, donor1	11473-119C6	127.48	32.95	7.12	9.29	3.44	2.93	2.29	3.31	0.64	0.25
Adipocyte - omental, donor2	11474-119C7	117.36	52.32	11.96	2.24	5.23	4.48	1.49	4.48	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	87.75	38.18	12.39	1.67	5.69	3.01	1.34	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	91.87	31.26	8.93	1.91	1.91	0.00	1.91	2.55	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	36.28	14.29	1.10	2.20	1.10	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	66.84	11.74	4.06	1.81	0.90	2.71	1.35	0.00	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	51.96	18.25	5.39	0.00	0.00	0.87	0.35	0.35	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	113.43	62.58	14.47	8.02	3.52	3.32	1.17	1.37	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	72.84	25.48	7.21	0.77	1.29	1.29	1.03	1.03	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	107.61	25.65	9.20	5.58	1.12	2.23	1.67	1.39	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	87.58	21.75	9.99	2.94	0.59	1.76	2.35	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	129.90	29.92	9.81	11.18	0.32	6.92	0.88	0.80	0.00	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	82.63	21.62	5.49	2.58	0.97	4.84	0.97	0.97	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	101.31	20.79	4.80	4.27	1.60	3.20	3.73	0.53	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	75.68	8.35	3.90	3.90	0.00	1.67	0.56	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	109.38	27.45	8.73	8.32	0.00	7.49	0.83	0.83	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	79.37	15.57	5.78	7.03	0.00	7.03	1.00	0.75	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	95.88	20.29	8.51	7.53	0.98	8.18	2.29	0.33	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	78.86	22.23	3.65	5.48	0.00	4.87	1.22	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	93.26	41.33	6.63	3.54	3.98	2.43	0.66	2.43	0.66	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	151.32	86.78	9.68	1.79	5.74	1.79	2.15	4.30	1.08	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	121.00	52.71	11.98	1.20	5.99	4.79	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	49.11	22.49	5.94	3.60	0.54	0.36	0.18	0.72	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	43.51	25.10	6.69	5.02	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	76.02	34.72	6.78	3.90	0.41	0.62	0.21	2.26	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	104.24	35.82	6.87	4.00	3.20	3.32	1.72	2.17	1.60	0.46
Anulus Pulposus Cell, donor2	11463-119B5	84.00	57.55	9.31	2.69	6.12	3.92	1.47	1.96	0.73	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	78.18	39.54	5.39	2.70	6.29	1.35	3.59	4.94	3.15	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	90.30	45.58	7.38	3.47	4.34	2.17	6.08	4.34	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	72.77	29.96	6.42	2.14	0.00	6.42	2.14	2.14	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	74.73	39.76	8.37	2.39	3.89	2.09	5.68	1.79	2.09	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	127.73	45.53	5.06	6.32	3.79	1.26	2.53	2.53	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	77.89	71.95	5.94	2.64	2.64	1.98	5.28	1.32	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	68.88	36.71	7.47	2.60	4.55	0.65	1.95	1.62	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	95.63	54.85	5.34	1.46	8.25	0.97	3.88	1.94	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	82.55	37.41	3.56	1.19	1.78	0.59	4.75	1.19	1.78	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	68.92	43.69	4.90	2.26	7.91	0.38	3.39	2.64	1.88	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	76.92	38.46	5.81	5.81	6.53	3.63	2.90	2.18	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	91.53	47.64	6.27	3.76	6.27	1.25	6.27	2.51	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	91.76	37.72	7.25	2.97	4.12	1.48	1.48	1.81	1.65	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	81.89	49.13	6.82	0.00	5.46	2.73	4.09	2.73	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	79.77	55.04	9.95	2.26	4.07	1.36	1.51	2.11	0.75	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	76.08	40.72	5.89	1.61	9.11	1.61	2.68	2.68	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	89.37	67.45	10.01	1.51	4.35	0.94	3.40	2.08	2.08	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	81.79	46.51	5.08	2.41	5.88	2.67	4.81	2.14	1.60	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	83.89	41.94	1.95	3.90	3.90	0.98	4.88	4.88	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	87.08	62.86	8.62	2.99	4.98	1.16	2.99	3.65	1.49	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	80.45	31.22	6.00	1.20	3.60	1.20	8.41	0.00	4.80	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	10.62	3.54	7.08	3.54	3.54	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	77.19	75.13	11.66	2.23	7.89	1.54	2.57	2.74	0.86	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	54.53	20.97	0.00	8.39	0.00	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	83.98	43.20	6.31	1.94	5.83	2.43	2.91	2.43	1.94	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	92.97	58.44	11.38	1.90	5.69	1.14	1.90	2.28	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	90.85	46.03	7.27	2.42	2.42	1.21	2.42	6.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	80.94	49.59	9.69	1.71	4.56	1.71	3.99	2.28	2.28	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	92.78	66.06	7.70	2.57	7.70	1.28	2.35	2.14	2.14	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	78.20	65.04	6.45	2.06	8.00	1.55	3.36	2.06	1.81	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	84.46	57.24	7.04	2.82	5.16	0.94	3.28	1.88	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	89.71	74.60	9.65	2.89	7.72	1.93	2.89	1.61	1.93	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	81.33	56.36	8.56	1.43	5.71	0.00	3.57	3.57	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	78.38	35.68	8.19	2.34	11.70	1.17	2.34	1.75	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	81.59	75.57	9.33	3.01	9.94	2.11	3.31	1.81	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	76.03	89.10	11.88	5.94	8.32	0.00	7.13	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	100.19	50.86	5.09	3.05	5.59	1.02	3.56	4.07	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	83.28	68.26	10.95	1.78	6.88	2.04	2.80	3.06	2.80	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	73.70	55.28	7.62	3.18	5.08	1.27	4.45	2.54	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	78.54	44.45	9.49	2.16	2.59	1.73	3.02	3.88	2.59	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	79.59	72.18	10.58	2.54	5.50	1.69	1.69	2.96	1.06	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	71.92	59.16	6.38	2.90	8.99	2.90	2.61	1.45	1.45	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	86.92	41.57	7.56	1.89	9.45	2.83	3.78	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	79.34	82.05	10.68	3.22	8.48	0.85	1.86	3.39	1.36	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	74.12	41.69	4.63	0.00	2.32	4.63	2.32	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	57.04	29.58	4.23	4.23	10.56	2.11	2.11	6.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	72.90	68.83	9.65	2.57	5.36	0.86	2.14	2.79	2.14	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	58.36	51.74	3.61	0.00	3.01	1.80	3.61	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	78.00	34.99	2.92	0.73	3.64	0.73	2.19	2.92	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	97.70	64.14	11.03	2.53	7.13	2.07	3.91	2.76	1.38	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	73.96	61.21	5.10	0.00	5.10	0.00	5.10	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	74.24	35.08	8.14	2.29	4.58	1.27	1.27	1.78	0.76	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	87.94	62.55	9.70	4.34	4.54	1.24	2.48	3.10	1.65	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	82.93	51.41	5.20	1.22	4.90	2.45	3.06	1.84	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	82.22	45.89	5.74	2.39	3.82	1.91	2.87	1.43	1.91	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	87.81	68.07	7.32	3.33	3.99	2.22	1.55	3.55	1.33	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	67.14	45.77	6.10	1.53	4.58	0.00	6.10	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	68.13	35.45	5.54	0.55	2.77	1.11	2.77	1.66	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	73.88	60.90	7.94	3.97	5.83	1.85	2.38	2.38	1.06	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	80.69	54.88	8.00	4.00	6.18	0.00	2.54	2.18	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	83.15	34.02	10.32	1.11	0.49	1.60	0.86	2.33	0.49	0.86
Astrocyte - cerebellum, donor2	11580-120F5	105.95	103.04	15.92	3.25	4.62	2.40	1.37	2.74	1.88	0.51
Astrocyte - cerebellum, donor3	11661-122F5	71.94	57.26	8.81	1.68	0.63	1.47	0.63	1.68	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	71.11	41.83	11.85	2.09	0.35	2.09	0.70	2.79	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	77.49	61.80	13.10	2.26	1.94	2.75	1.46	1.46	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	59.96	65.18	15.51	1.79	1.79	1.94	1.49	1.79	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	117.78	51.04	7.11	11.47	0.69	0.57	1.72	0.69	0.57	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	114.38	55.50	9.52	12.65	1.88	0.63	1.25	1.00	0.25	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	104.92	50.41	5.92	12.52	1.71	0.80	0.91	1.48	0.46	0.57
Basophils, donor1	12241-129G9	175.23	42.89	2.88	3.66	3.92	0.52	1.05	0.78	3.14	0.78
Basophils, donor2	12242-129H1	213.59	92.72	6.13	9.02	12.63	2.16	3.97	1.08	9.74	5.05
Basophils, donor3	12243-129H2	153.32	66.88	9.11	7.35	7.35	2.06	2.35	0.29	2.94	4.56
Bronchial Epithelial Cell, donor1	11511-119G8	111.47	29.54	6.04	8.62	2.80	2.37	1.72	1.94	1.29	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	184.25	82.75	10.06	15.54	6.40	2.74	3.20	2.74	1.37	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	78.91	14.35	14.35	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	168.21	37.66	10.04	5.02	5.65	0.63	1.26	0.63	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	166.78	74.65	11.23	6.24	6.86	1.87	1.66	1.04	1.04	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	129.42	42.14	5.99	2.99	3.68	1.15	2.99	0.92	1.15	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	75.04	59.02	3.24	4.68	2.16	1.08	1.26	1.62	0.90	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	56.99	37.10	5.36	19.58	0.00	0.93	0.72	0.21	0.00	2.37
Burkitt's lymphoma cell line:RAJI	10476-106I8	71.04	35.63	6.29	13.97	0.00	2.10	0.23	0.23	0.00	4.66
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	129.83	66.51	6.72	1.60	0.64	0.64	0.32	1.28	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	268.89	93.08	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	129.05	49.59	5.07	0.56	8.45	1.69	0.56	0.00	2.25	7.33
CD14+ Monocytes, donor2	11305-117B9	74.43	63.10	3.90	0.37	11.51	0.37	1.11	0.37	2.97	0.37
CD14+ Monocytes, donor3	11381-118B4	94.62	110.43	7.68	3.07	15.81	4.17	2.85	0.22	3.07	3.51
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	76.42	18.96	7.64	5.38	1.42	0.85	1.13	0.85	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	81.50	37.15	9.10	7.96	1.90	1.90	1.90	1.14	0.38	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	71.34	30.24	11.51	1.31	0.99	0.33	0.00	0.00	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	63.31	17.78	2.31	0.72	0.72	0.14	0.87	0.29	0.29	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	62.46	24.14	1.21	1.81	1.81	0.00	2.41	0.30	0.91	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	58.99	18.95	0.95	1.18	0.47	0.47	1.18	0.00	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	44.86	14.56	2.01	0.84	0.33	0.17	0.84	0.00	0.00	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	44.99	20.98	0.83	0.55	0.83	0.55	0.55	0.55	0.28	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	53.55	16.36	1.74	0.74	0.00	0.00	0.74	0.25	0.00	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	53.26	16.64	0.98	0.39	0.78	0.20	0.59	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	67.12	22.43	1.42	1.96	0.89	0.71	2.31	0.36	0.00	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	77.69	11.97	2.18	2.61	0.44	1.09	1.31	0.22	0.00	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	48.00	11.00	1.64	0.23	0.70	0.00	0.94	0.00	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	64.42	17.42	1.58	1.58	0.00	1.58	1.06	0.53	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	46.59	7.77	0.00	0.00	2.22	1.11	0.00	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	54.74	14.43	2.83	0.74	0.59	0.45	0.89	0.00	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	46.89	17.76	1.00	1.20	0.80	0.20	1.60	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	42.06	9.58	0.83	1.46	0.21	0.62	0.62	0.42	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	52.62	14.41	2.29	0.46	0.46	0.23	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	64.24	11.99	1.36	1.13	1.13	0.23	0.45	0.68	0.00	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	45.39	18.33	2.62	0.00	1.31	0.87	0.44	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	65.90	14.79	0.81	0.54	0.00	0.00	1.61	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	87.58	31.05	2.62	2.79	1.22	2.62	2.44	0.17	0.87	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	66.07	23.15	1.26	1.26	1.68	0.84	0.84	0.00	0.00	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	50.52	9.37	0.55	0.92	0.73	0.00	0.73	0.18	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	47.56	18.32	0.35	2.11	0.35	0.70	0.70	0.70	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	39.05	9.65	0.44	0.44	0.00	0.00	0.88	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	62.08	13.78	3.49	0.87	0.87	0.52	1.57	0.17	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	75.82	27.88	2.23	1.49	2.23	0.00	2.97	0.00	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	88.16	15.30	3.88	2.37	1.08	1.51	0.65	0.65	0.86	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	53.23	16.38	2.46	0.82	2.05	0.41	0.82	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	52.62	11.36	0.70	0.70	0.46	0.23	0.70	0.00	0.23	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	41.06	7.66	0.46	1.86	1.16	0.23	0.70	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	108.11	11.33	2.40	6.10	1.96	1.53	1.53	0.00	0.22	6.76
CD14+CD16+ Monocytes, donor2	11801-124D1	115.73	11.09	1.62	6.47	0.23	2.54	0.69	0.23	0.00	8.08
CD14+CD16+ Monocytes, donor3	11912-125G4	103.98	12.56	3.25	9.53	0.43	2.60	0.87	0.43	0.22	6.50
CD14+CD16- Monocytes, donor1	11788-124B6	145.76	16.04	4.36	4.20	0.00	1.71	0.93	0.62	0.16	4.36
CD14+CD16- Monocytes, donor2	11799-124C8	119.98	12.40	2.10	3.14	0.52	2.62	0.70	0.00	0.17	3.32
CD14+CD16- Monocytes, donor3	11910-125G2	130.44	17.17	2.45	6.47	0.67	2.68	0.89	0.00	0.00	5.13
CD14-CD16+ Monocytes, donor1	11790-124B8	125.04	9.44	1.02	3.32	1.28	1.53	0.77	0.00	0.00	4.08
CD14-CD16+ Monocytes, donor2	11800-124C9	123.40	8.12	1.76	3.73	0.66	1.76	1.10	0.22	0.00	3.73
CD14-CD16+ Monocytes, donor3	11911-125G3	153.28	7.58	2.95	7.37	0.21	3.58	0.42	0.00	0.00	11.58
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	300.78	182.91	20.32	0.00	18.29	0.00	26.42	0.00	24.39	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	294.92	189.83	15.59	2.71	31.86	0.00	16.95	0.00	30.51	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	304.47	166.73	12.43	5.18	20.71	0.00	19.68	0.00	22.78	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	291.57	134.86	16.52	4.26	23.45	0.53	15.46	0.53	26.12	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	331.83	243.91	25.73	4.82	33.77	0.54	24.12	2.14	40.74	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	252.00	145.30	17.55	4.21	18.95	0.70	16.14	0.70	28.78	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	301.19	211.78	12.55	1.57	30.59	1.57	22.75	0.78	36.86	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	303.21	177.97	17.14	7.91	22.41	0.00	9.23	0.00	27.68	0.00
CD19+ B Cells, donor1	11544-120B5	250.68	295.06	9.86	4.93	35.34	0.00	13.15	0.00	23.01	0.00
CD19+ B Cells, donor2	11624-122B4	213.28	196.59	6.53	15.96	20.31	0.73	5.80	0.00	12.33	0.73
CD19+ B Cells, donor3	11705-123B4	193.85	240.30	13.13	0.50	46.44	1.01	11.11	0.50	8.08	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	181.83	3.23	2.02	12.93	0.40	4.85	1.62	0.00	0.40	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	160.60	3.20	2.00	13.58	0.00	3.99	0.80	0.00	0.00	1.20
CD34+ Progenitors, donor1	11545-120B6	57.23	56.23	4.02	1.00	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	53.37	39.89	4.49	2.25	2.81	1.12	0.56	1.12	3.93	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	77.03	60.87	6.39	5.64	1.13	1.50	0.38	0.75	0.75	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	103.05	55.02	5.41	4.74	1.13	1.13	1.58	1.35	0.00	3.16
CD4+ T Cells, donor1	11225-116C1	89.98	343.85	11.43	12.50	88.91	2.14	4.64	2.14	26.78	5.36
CD4+ T Cells, donor2	11306-117C1	124.92	456.82	8.57	3.06	121.25	0.61	17.15	3.06	22.05	0.00
CD4+ T Cells, donor3	11382-118B5	117.73	531.91	18.30	10.06	107.97	3.66	10.98	1.83	24.40	7.01
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	108.48	307.05	5.62	16.34	113.07	3.57	66.11	2.81	98.52	13.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	101.07	498.38	11.01	17.52	162.38	4.72	70.75	1.35	112.30	13.03
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	115.85	458.21	10.35	26.45	167.01	3.74	78.48	2.87	118.15	25.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	114.26	332.34	12.33	12.33	91.97	4.74	21.81	1.42	65.42	7.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	173.47	301.30	14.75	7.73	112.37	5.62	30.20	1.40	69.53	7.73
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	148.33	293.36	13.18	26.37	151.63	0.00	23.07	0.00	39.55	13.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	153.04	204.92	7.23	20.38	62.00	2.89	29.05	0.43	38.73	9.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	128.45	608.54	14.23	24.40	135.23	4.24	32.03	1.69	46.77	20.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	125.26	501.99	14.99	32.89	116.23	8.87	37.24	0.48	47.72	29.02
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	142.56	287.81	7.17	13.00	76.66	4.93	36.31	0.00	61.87	8.52
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	164.21	335.41	8.73	16.42	81.41	2.10	49.26	1.05	70.93	14.32
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	139.91	327.79	10.56	26.84	76.12	2.64	39.60	0.44	62.04	21.56
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	97.82	167.39	8.43	21.50	50.18	0.42	18.55	1.26	27.41	3.79
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	88.72	424.89	11.43	16.41	63.79	2.29	9.97	2.08	9.97	7.90
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	88.54	368.21	9.36	24.73	58.47	2.67	12.70	0.00	20.05	12.70
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	105.24	306.47	7.61	18.76	118.56	2.45	12.51	1.90	44.60	8.97
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	128.09	304.42	4.82	19.29	117.37	3.22	18.76	0.54	45.56	8.58
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	89.66	450.10	14.35	34.07	157.80	3.59	26.90	0.00	52.00	16.14
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	136.10	250.88	6.49	22.07	57.30	2.97	14.09	2.78	31.15	10.01
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	148.60	345.29	13.65	24.04	67.15	3.03	10.40	0.65	24.69	12.13
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	198.80	373.02	18.70	42.87	77.76	4.41	10.93	1.68	21.44	16.39
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	132.47	251.29	9.10	14.66	58.65	2.53	18.20	2.02	23.26	9.10
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	143.84	310.21	10.40	19.50	75.39	2.60	18.63	3.47	36.83	12.13
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	129.00	244.06	7.84	27.46	69.29	5.67	13.51	0.87	18.30	20.48
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	180.63	314.74	17.82	6.93	78.68	0.49	13.36	2.47	38.10	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	191.10	230.80	18.46	7.39	46.16	0.00	12.92	1.85	29.54	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	187.04	266.60	25.12	5.58	69.79	0.00	8.37	1.40	26.52	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	213.79	168.93	14.68	5.82	72.83	1.38	11.08	0.83	37.39	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	208.58	211.53	16.69	3.19	77.54	2.45	17.42	1.23	41.47	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	186.34	195.58	10.78	7.70	52.36	0.00	9.24	0.00	38.50	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	190.16	296.52	19.70	3.94	80.93	0.72	14.68	1.43	33.66	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	296.39	290.85	24.93	4.15	65.09	2.77	13.85	0.00	38.78	0.00
CD8+ T Cells, donor1	11226-116C2	204.62	236.05	16.37	6.22	59.26	5.57	6.22	1.96	21.94	6.22
CD8+ T Cells, donor2	11307-117C2	174.95	326.63	14.64	1.50	73.96	2.25	10.51	0.00	25.53	1.13
CD8+ T Cells, donor3	11383-118B6	150.99	439.84	20.45	12.62	98.47	5.05	7.32	0.76	22.98	9.34
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	38.54	22.94	1.15	9.41	1.15	0.92	0.69	0.23	0.23	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	43.85	21.81	2.16	6.95	0.24	2.16	1.44	0.96	0.24	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	44.87	17.51	1.09	12.59	0.27	0.82	0.55	0.27	0.00	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	33.62	13.81	0.60	8.71	0.00	1.80	1.50	0.00	0.30	2.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	58.08	17.52	2.16	11.28	0.00	1.20	0.48	0.24	0.24	2.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.89	26.15	2.73	10.46	0.23	0.68	0.68	0.45	0.00	5.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	44.33	33.24	3.04	13.04	0.00	1.09	0.65	0.87	0.00	4.56
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	37.64	37.11	3.95	12.63	0.26	0.79	0.79	0.26	0.00	4.21
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	38.93	30.96	3.28	10.32	0.47	0.94	1.88	0.00	0.00	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	41.36	32.30	3.32	14.79	0.00	1.81	0.91	0.30	0.00	2.72
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	48.51	32.83	3.20	10.75	0.00	0.29	2.03	0.58	0.00	4.65
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	46.89	39.17	3.46	10.92	0.27	0.80	1.07	0.27	0.00	3.46
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	36.77	23.20	1.75	4.38	0.44	0.44	1.75	0.00	0.00	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	36.89	24.59	3.64	7.74	0.46	1.37	0.00	0.00	0.00	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	24.61	35.06	1.49	6.71	0.00	2.98	0.00	0.00	0.00	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	47.54	27.73	1.80	7.20	0.72	2.16	0.36	0.36	0.36	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	43.16	28.48	2.59	8.63	0.58	1.44	0.00	0.29	0.00	4.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	49.02	26.87	2.36	9.43	0.47	1.41	0.24	0.47	0.00	2.59
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	43.42	34.54	2.85	6.02	0.32	1.58	0.63	0.63	0.32	5.39
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	53.52	35.98	2.46	8.61	0.31	1.54	0.62	0.31	0.00	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	47.13	39.75	5.77	9.62	0.64	1.60	0.64	0.64	0.00	3.21
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	55.46	30.98	0.76	9.94	0.00	1.91	1.15	0.00	0.00	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	48.47	25.62	2.76	9.06	0.00	0.39	1.18	0.00	0.00	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	45.38	21.94	0.76	6.05	0.00	0.76	0.00	2.27	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	39.34	7.23	2.41	4.01	0.00	0.80	0.80	0.00	0.00	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	51.06	13.99	2.80	3.50	0.00	0.00	0.00	0.00	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	56.10	13.02	2.00	5.01	1.00	0.00	1.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	107.84	40.21	3.66	1.83	14.62	1.83	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	55.83	46.94	3.46	1.48	3.46	1.48	0.99	1.48	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	67.14	34.52	7.05	1.79	1.05	1.05	0.42	1.47	0.63	0.21
Chondrocyte - de diff, donor1	11261-116G1	29.47	24.61	7.28	2.08	2.77	2.43	1.39	1.73	0.35	0.69
Chondrocyte - de diff, donor2	11338-117F6	94.53	17.41	5.69	1.42	1.42	2.49	1.78	0.71	0.00	1.07
Chondrocyte - de diff, donor3	11410-118E6	66.45	31.29	6.26	5.01	1.71	6.03	2.50	2.50	0.23	0.91
Chondrocyte - re diff, donor2	11339-117F7	27.75	8.95	2.69	1.79	0.00	0.90	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	78.05	27.90	2.43	3.24	0.40	4.45	1.62	1.62	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	71.72	32.13	7.34	2.98	0.46	1.95	0.80	2.75	0.23	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	56.86	42.11	4.92	2.35	0.64	1.07	2.14	1.50	0.21	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	68.94	59.21	10.62	2.48	0.71	1.24	0.97	1.50	0.35	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	202.38	35.30	9.26	6.24	5.69	4.77	2.02	2.66	4.86	1.38
Corneal Epithelial Cells, donor1	11526-119I5	117.25	36.45	7.25	6.15	0.44	1.98	0.88	1.98	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	98.97	7.96	1.14	13.65	1.14	0.00	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	108.64	36.56	7.16	9.46	2.56	2.30	1.28	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	170.05	31.86	10.24	17.00	0.66	4.95	1.49	0.83	0.17	12.55
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	141.30	24.92	8.20	19.56	2.21	3.47	1.89	0.32	0.00	11.04
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	141.48	10.35	10.35	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	87.36	29.70	5.62	6.48	0.65	0.76	1.08	0.97	0.22	1.62
Dendritic Cells - plasmacytoid, donor1	11228-116C4	160.23	98.39	16.06	7.52	4.78	0.00	2.05	0.68	2.05	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	152.12	101.19	20.89	7.18	5.88	1.31	3.26	0.65	0.65	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	216.32	85.17	20.81	3.39	3.39	0.00	1.94	1.94	1.94	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	78.21	48.53	4.17	7.34	2.00	2.84	0.83	4.67	0.50	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	69.83	72.17	2.93	0.00	2.35	0.59	0.59	5.28	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	96.15	60.52	2.55	5.37	3.39	4.52	0.85	4.52	0.57	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	92.01	98.30	4.72	5.11	3.54	4.72	0.79	3.54	1.18	2.36
Endothelial Cells - Artery, donor1	11264-116G4	63.70	121.88	6.98	2.62	2.62	4.94	2.04	4.65	0.87	2.04
Endothelial Cells - Artery, donor2	11341-117F9	73.88	120.23	3.53	6.12	4.47	4.71	3.76	6.35	1.88	0.94
Endothelial Cells - Artery, donor3	11413-118E9	69.42	78.71	6.49	1.58	2.45	1.75	2.10	2.10	0.70	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	65.17	29.92	2.22	3.77	0.22	2.66	0.44	1.99	0.00	2.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	73.02	38.03	4.26	3.35	0.61	1.83	0.00	3.35	0.00	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	45.95	34.11	2.82	2.26	1.13	1.13	0.28	2.82	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	50.51	44.57	4.75	1.49	1.49	0.89	1.49	4.16	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	74.46	39.05	3.12	4.69	1.04	0.52	0.52	3.64	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	50.62	77.42	5.39	1.56	0.43	0.43	1.56	3.26	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	78.02	40.81	4.80	1.20	1.60	3.20	2.00	5.60	0.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	68.14	95.39	3.14	2.10	2.62	1.05	3.67	8.39	3.14	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	72.19	48.58	2.98	6.96	0.62	8.70	1.24	2.36	0.25	3.60
Endothelial Cells - Umbilical vein, donor2	11324-117E1	74.09	103.42	5.00	5.43	0.65	7.82	0.22	3.69	0.22	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	64.36	101.85	5.37	2.69	1.47	2.81	0.24	4.15	0.00	1.10
Endothelial Cells - Vein, donor1	11267-116G7	69.39	125.13	7.96	3.41	0.00	2.28	0.00	5.69	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	98.49	60.77	1.40	2.10	1.40	1.40	2.10	8.38	0.00	2.79
Endothelial Cells - Vein, donor3	11416-118F3	119.17	135.50	8.32	8.32	2.51	5.18	2.98	8.48	1.10	2.04
Eosinophils, donor1	12244-129H3	350.68	137.22	0.00	0.00	15.25	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	79.21	31.35	1.65	1.65	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	117.71	24.97	3.57	0.00	3.57	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	96.26	27.36	6.35	7.57	4.40	4.15	0.98	0.98	1.22	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	106.09	27.04	4.16	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	65.08	0.00	0.00	0.00	0.00	16.27	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	81.69	58.29	13.55	3.28	1.64	1.64	1.64	3.69	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	74.34	28.80	4.71	2.96	3.07	1.86	4.49	2.08	0.55	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	112.13	38.78	6.93	4.98	4.01	2.49	3.14	1.30	0.65	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	74.83	29.71	7.76	2.18	3.03	0.97	3.88	2.30	0.73	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	55.54	10.24	2.32	0.96	0.96	0.55	0.41	1.77	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	81.84	37.23	7.49	2.53	4.96	1.90	3.48	2.74	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.83	5.01	0.26	2.63	1.05	0.79	0.53	0.79	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	72.09	42.85	7.64	3.32	2.99	1.33	1.99	1.99	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	90.73	50.81	9.07	3.18	1.81	0.00	1.81	2.72	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	103.84	36.38	2.27	0.00	2.27	1.52	3.03	3.03	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	82.17	63.56	12.14	3.00	2.84	1.58	1.89	4.57	0.32	0.47
Fibroblast - Cardiac, donor4	11452-119A3	53.95	40.92	8.18	2.12	3.03	2.12	0.61	1.52	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	70.18	60.28	5.33	2.28	3.55	1.52	1.40	2.03	1.02	0.63
Fibroblast - Cardiac, donor6	11460-119B2	60.79	60.49	6.67	0.91	3.64	1.52	1.06	1.36	0.61	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	81.20	24.12	9.38	0.94	0.67	1.34	0.67	2.41	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	66.87	41.42	9.49	0.00	1.29	0.43	0.43	1.73	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	57.13	51.27	4.39	0.00	0.00	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	149.22	37.59	7.84	6.00	4.38	2.54	1.15	1.61	1.15	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	90.74	36.97	8.99	0.17	6.44	0.68	3.22	2.88	3.05	0.00
Fibroblast - Dermal, donor1	11269-116G9	64.56	30.05	4.23	3.05	4.46	2.35	2.82	0.94	0.47	0.70
Fibroblast - Dermal, donor2	11346-117G5	69.34	23.58	7.08	2.83	2.83	0.94	1.89	1.89	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	81.48	28.41	6.41	3.02	3.02	3.26	0.85	1.69	0.60	0.36
Fibroblast - Dermal, donor4	11450-119A1	49.17	28.37	4.97	3.39	2.60	1.58	0.79	0.45	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	55.48	27.56	3.84	2.62	2.27	0.52	1.22	1.57	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	51.98	33.62	5.68	2.76	2.11	1.30	0.97	0.49	0.49	0.00
Fibroblast - Gingival, donor1	11237-116D4	78.29	21.24	5.62	0.83	3.54	1.25	0.62	1.46	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	124.71	39.04	10.48	5.76	7.07	3.93	3.41	3.14	1.31	0.52
Fibroblast - Gingival, donor2	11318-117D4	68.00	52.32	7.64	3.16	3.69	1.98	1.84	1.45	1.71	0.13
Fibroblast - Gingival, donor3	11394-118C8	91.37	39.35	7.93	0.58	6.28	1.35	1.55	1.74	1.06	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	119.47	44.67	12.47	5.19	4.16	1.04	2.08	9.35	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	106.25	39.82	8.11	4.23	4.93	4.05	4.76	1.59	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	98.99	42.87	9.82	2.18	4.52	1.09	1.71	2.18	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	115.21	33.13	10.01	3.38	5.41	1.49	2.30	0.81	0.54	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	122.10	39.52	13.06	1.06	4.94	0.35	1.76	2.47	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	105.30	39.49	10.82	1.46	4.39	0.88	2.05	3.80	0.58	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	95.31	27.00	5.73	3.27	4.64	1.77	0.82	1.50	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	111.01	40.15	7.57	1.76	3.40	0.44	0.88	0.99	0.88	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	136.47	44.17	10.86	3.37	9.83	1.61	4.55	5.28	1.76	0.44
Fibroblast - Lung, donor1	11270-116H1	126.42	63.89	8.16	5.44	10.87	0.00	4.08	2.72	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	86.54	34.32	7.46	1.49	7.46	0.00	2.98	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	105.94	78.51	12.87	4.85	13.08	2.32	5.91	2.32	2.32	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	135.78	16.66	5.83	2.50	7.50	2.50	0.00	1.67	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	76.92	34.97	9.79	2.80	6.99	5.59	0.00	0.00	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	103.55	36.38	6.44	3.08	4.76	3.36	2.52	1.40	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	66.58	28.01	4.47	2.84	2.84	2.03	0.00	0.41	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	99.86	63.91	0.00	0.00	3.99	7.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	89.34	0.00	0.00	11.91	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	94.47	23.47	9.12	5.04	2.52	2.72	1.16	1.36	0.97	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	81.45	56.12	7.13	1.97	4.85	2.58	1.67	1.06	1.52	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	68.54	32.74	11.32	0.61	4.59	0.92	0.61	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	80.90	48.47	9.92	0.76	5.72	1.91	2.29	2.67	1.53	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	96.39	36.72	13.50	2.97	5.13	1.35	3.78	4.32	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	97.77	47.09	10.44	4.99	4.41	4.06	2.44	2.44	0.70	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	63.34	35.04	7.41	2.21	1.44	2.32	0.77	1.66	0.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	115.01	40.23	6.50	9.14	5.28	3.45	4.06	1.42	4.06	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	88.20	48.78	7.35	2.00	5.35	2.00	0.67	2.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	67.21	48.23	7.12	1.19	6.33	1.19	2.37	3.56	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.97	5.16	1.59	3.57	0.79	0.60	0.40	0.40	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	77.26	17.05	5.68	1.24	3.91	1.42	0.53	1.60	0.53	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	72.72	16.56	5.12	2.37	1.38	0.79	1.18	1.38	0.99	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	36.70	6.02	2.11	2.71	0.90	0.90	0.60	1.50	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	86.69	19.22	5.40	5.61	3.56	2.48	0.97	2.70	0.76	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	36.70	3.04	1.01	0.76	1.01	0.25	0.25	1.27	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	75.80	24.94	8.70	3.61	2.46	2.13	0.98	1.64	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	44.71	11.63	4.61	1.60	1.40	0.00	0.80	1.00	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	65.50	18.79	6.13	3.42	5.12	1.00	1.31	1.00	0.40	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	34.76	3.93	1.81	2.42	2.12	1.51	0.60	2.12	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	94.86	17.65	6.54	4.23	3.56	2.57	1.49	3.81	0.17	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	109.24	23.25	8.89	2.56	8.72	2.22	3.42	1.88	4.44	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	30.22	5.25	2.30	1.64	1.31	0.66	0.00	1.64	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	61.36	18.85	6.71	2.77	3.20	1.70	1.17	2.34	0.21	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	80.46	25.81	4.39	2.02	2.53	1.35	0.84	2.36	0.84	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	67.43	14.90	3.45	3.92	1.10	1.57	1.73	1.25	0.63	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	74.08	32.25	5.23	4.36	0.87	1.74	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	132.10	31.03	9.36	0.87	3.47	0.87	1.73	1.73	1.21	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	84.06	51.01	10.67	5.47	2.86	1.82	1.30	1.82	0.26	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	88.66	56.47	12.78	2.04	6.13	0.51	1.28	2.30	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	89.57	47.46	7.66	6.89	0.00	0.00	2.30	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	73.38	33.82	5.10	9.57	2.55	0.00	5.10	0.64	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	66.47	83.30	9.41	7.70	0.29	0.29	3.14	1.14	0.00	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	50.19	68.39	9.65	0.55	0.28	0.00	1.10	0.28	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	57.99	53.66	12.79	1.60	0.23	0.00	2.28	1.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	56.07	96.09	11.10	3.37	0.79	0.79	1.39	1.59	0.40	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	50.22	66.35	11.90	0.26	0.26	0.00	1.06	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	63.92	65.88	11.74	1.30	0.00	0.65	1.30	1.63	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	70.76	110.11	10.61	11.50	1.77	1.77	2.21	2.21	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	44.09	58.65	7.49	4.66	0.57	0.28	2.54	1.98	0.71	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	40.39	51.72	4.93	2.09	0.62	0.86	1.11	1.85	0.12	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	33.31	46.74	3.22	3.22	0.81	0.54	1.61	2.69	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	39.15	49.68	6.57	1.73	0.12	0.25	1.49	1.24	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.96	43.33	5.81	3.32	0.42	0.14	0.55	1.94	0.83	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.34	34.76	5.90	3.46	1.22	0.41	1.63	0.61	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	44.95	53.62	6.85	3.65	1.14	0.68	1.83	3.88	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	42.98	64.15	6.35	4.98	1.12	0.62	1.62	3.61	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	38.91	82.18	6.99	5.90	2.62	0.22	1.09	3.50	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	43.14	60.28	4.73	1.77	0.30	0.30	1.77	4.43	0.59	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	47.37	48.16	5.72	2.70	0.32	0.79	0.64	2.07	0.48	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.79	79.31	7.60	3.80	0.89	0.45	1.56	4.69	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	62.51	56.46	6.65	1.61	0.60	0.40	2.42	4.23	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	61.75	41.39	4.75	2.71	0.51	0.17	1.02	2.71	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.99	35.29	4.34	3.64	0.98	0.53	0.98	2.75	0.44	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.56	58.48	4.99	3.02	1.14	1.35	1.35	4.68	0.62	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.72	56.19	3.24	2.73	1.54	0.51	1.88	4.44	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	65.51	62.08	5.53	2.88	0.77	1.00	0.89	3.32	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	58.32	36.61	6.49	3.66	0.67	0.83	0.58	2.16	0.42	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.13	25.73	4.70	2.86	1.02	0.20	0.82	1.84	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	60.03	63.34	5.57	2.48	0.62	1.03	2.48	2.89	1.03	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	60.99	64.22	6.34	1.84	0.35	0.58	1.50	3.34	0.23	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	55.37	56.20	6.84	1.67	0.83	0.33	1.33	3.17	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	66.57	74.51	5.95	3.31	2.42	1.10	1.54	3.97	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.11	84.50	6.52	2.21	1.35	1.35	1.84	4.18	0.25	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	71.48	57.06	7.62	3.08	0.16	1.30	0.97	2.92	0.49	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	62.86	91.08	5.77	2.25	1.28	0.96	1.28	3.21	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	79.88	63.39	7.30	4.17	0.95	0.85	1.33	4.83	0.19	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	58.53	63.59	4.75	3.48	1.27	1.11	0.47	3.48	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	73.59	58.69	6.99	3.34	0.61	1.22	4.26	1.82	0.00	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	78.09	54.67	6.17	1.99	0.73	0.94	1.25	2.82	0.00	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	60.38	55.99	5.71	3.29	0.44	0.88	1.32	2.63	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	65.65	56.95	6.73	1.96	0.28	0.56	1.40	3.37	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	86.29	56.94	10.00	3.61	1.02	2.13	1.85	4.07	0.28	1.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	67.92	52.14	5.08	3.48	0.80	0.80	1.87	2.14	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	75.13	48.20	6.58	3.83	1.53	1.22	0.92	4.59	0.77	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	86.79	61.14	7.90	3.76	1.42	0.65	1.04	2.85	0.39	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	65.06	74.27	8.13	2.71	0.54	1.36	0.54	4.34	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	86.83	70.98	6.64	4.06	1.29	1.47	1.11	4.24	0.18	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	89.92	72.15	8.11	3.51	0.66	1.32	2.85	3.29	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	83.31	105.13	6.94	0.99	1.98	0.99	0.00	4.96	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	71.89	56.19	7.39	2.77	0.13	1.32	1.32	3.17	0.40	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	96.44	60.93	7.67	3.23	0.20	2.82	1.21	2.02	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	59.22	57.19	8.13	1.02	0.76	1.27	0.51	5.59	1.02	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	40.41	42.00	7.96	6.17	0.40	1.00	1.79	2.39	1.59	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	38.52	65.64	7.86	4.01	1.08	0.15	1.23	2.47	0.46	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.99	53.19	8.59	4.30	0.82	0.61	0.82	3.07	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	69.16	59.14	9.70	5.01	0.63	0.31	0.00	2.19	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	64.14	42.95	8.48	4.24	0.28	0.00	0.28	1.13	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	40.59	44.28	12.45	0.92	0.00	0.00	4.15	0.46	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	37.12	12.37	2.47	2.47	0.00	2.47	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	52.61	35.20	7.35	4.25	3.09	0.77	2.32	1.93	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	56.16	40.11	6.42	3.21	0.00	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	52.16	39.99	6.96	5.22	1.74	3.48	0.00	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	53.38	39.38	8.14	6.18	0.65	0.00	2.60	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.42	36.65	4.94	4.94	0.41	0.41	1.24	0.41	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	49.98	0.00	0.00	0.00	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	45.86	21.53	4.75	4.47	1.40	0.28	0.84	0.84	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	52.29	40.53	7.52	6.86	0.98	0.33	1.63	0.98	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	38.59	49.49	14.26	7.55	1.68	0.00	1.68	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	45.80	23.54	4.77	5.09	0.64	0.32	1.59	0.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.72	38.04	7.81	7.47	0.34	0.68	1.36	0.68	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	62.64	4.18	4.18	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	42.38	30.35	8.02	2.29	0.57	1.72	1.72	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	41.44	37.59	7.70	2.07	1.18	0.00	0.59	0.59	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	57.60	6.78	3.39	0.00	0.00	0.00	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	35.21	28.17	6.21	2.07	1.24	0.41	3.73	0.41	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	40.04	35.21	4.60	1.61	0.00	0.00	1.15	0.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	26.34	15.81	5.27	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	38.44	34.21	6.15	0.77	0.38	0.00	0.77	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	35.53	33.25	5.87	2.28	0.33	0.65	2.61	1.63	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	54.84	60.86	14.05	4.68	2.01	0.00	0.00	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	73.59	35.44	6.93	1.93	0.00	0.00	1.93	0.77	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	46.56	33.55	5.48	2.40	1.03	0.34	0.68	0.34	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	86.97	52.18	4.97	2.48	0.00	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	73.61	69.36	6.13	0.47	1.42	0.00	0.94	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	49.49	44.06	7.85	1.21	1.21	0.00	1.81	1.21	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	47.31	8.14	2.54	1.02	2.03	1.53	0.51	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	69.40	51.05	5.98	0.40	1.60	0.00	1.20	0.80	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	67.10	36.51	5.43	0.99	0.49	0.00	1.97	1.48	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	60.20	54.30	9.44	0.00	0.00	1.18	0.00	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	70.60	47.26	6.42	1.75	1.17	0.58	1.17	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.88	40.82	5.71	3.07	2.19	0.44	2.63	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.10	59.34	5.93	4.24	0.00	0.85	2.54	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	60.29	51.33	5.97	2.39	0.00	0.60	1.79	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	56.29	35.91	7.76	2.43	1.46	0.00	1.46	0.97	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	55.92	26.25	9.13	5.71	1.14	1.14	1.14	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	46.16	34.51	11.23	2.91	2.49	0.83	0.83	2.08	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	103.45	38.23	9.00	5.62	3.37	0.00	3.37	1.12	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	69.46	32.98	5.71	1.90	7.61	2.54	2.22	0.95	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	65.59	19.22	2.92	1.67	4.60	3.34	1.67	0.84	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	61.73	24.48	2.90	27.97	0.70	3.83	1.62	0.58	0.00	1.74
Hep-2 cells mock treated, biol_rep2	11899-125E9	57.90	20.26	3.54	25.32	0.17	5.57	1.18	0.17	0.17	3.21
Hep-2 cells mock treated, biol_rep3	11900-125F1	52.33	16.84	2.50	28.44	0.00	4.78	1.14	0.00	0.00	2.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	60.45	23.06	2.95	28.97	0.11	3.61	1.09	0.11	0.00	3.06
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	59.10	19.99	2.79	22.57	0.00	4.08	1.50	0.00	0.00	1.72
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	61.79	12.70	3.23	25.40	0.00	4.52	0.65	0.22	0.00	3.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	64.88	24.28	3.24	24.28	0.37	5.48	1.37	1.00	0.12	2.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	54.55	16.64	2.40	23.50	0.00	4.97	0.51	0.00	0.00	2.57
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	53.18	16.66	2.56	24.67	0.00	3.52	0.96	0.32	0.00	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	64.92	58.76	6.16	0.56	1.12	2.24	2.24	3.36	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	94.78	63.62	3.03	1.30	0.87	0.87	1.73	2.60	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	97.82	0.00	5.29	0.00	2.64	13.22	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	101.58	56.08	12.35	2.12	6.00	2.12	2.47	4.23	2.12	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	94.45	72.65	5.09	3.63	2.18	2.91	1.45	0.73	2.91	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	47.38	50.70	5.77	1.40	4.72	1.05	1.40	1.40	1.40	0.17
Hepatocyte, donor1	11523-119I2	83.53	8.47	6.05	6.05	0.00	2.42	1.21	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	118.51	17.24	6.46	3.23	0.00	2.15	2.15	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	78.53	22.09	3.68	1.84	0.61	6.14	0.00	0.61	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	62.66	106.39	5.87	45.04	0.65	1.31	5.87	0.65	0.00	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	76.03	17.65	2.80	0.70	0.00	0.70	1.40	0.70	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	51.04	36.63	7.68	2.20	2.61	0.96	0.96	1.37	0.69	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	105.07	28.66	6.37	0.00	3.18	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	180.23	40.05	13.35	0.00	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	99.68	23.53	5.54	2.77	6.92	0.00	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	137.65	35.04	2.50	0.00	7.51	0.00	12.51	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	12.81	2.56	0.00	2.56	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	127.98	54.85	0.00	4.57	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	125.07	45.48	1.62	1.62	3.25	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	95.04	35.01	8.34	0.00	5.00	0.00	3.33	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	83.50	7.26	0.00	0.00	0.00	0.00	3.63	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	123.08	25.15	2.65	3.97	2.65	0.00	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	85.37	27.72	9.98	1.11	3.33	1.11	2.22	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	110.00	26.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	96.37	27.71	3.15	2.52	1.26	1.26	1.26	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	94.34	21.65	3.09	0.00	3.09	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	137.61	32.95	6.46	0.00	1.29	0.00	0.65	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	98.21	35.42	9.66	0.00	6.44	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	47.79	0.00	0.00	0.00	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	125.49	37.48	4.07	0.00	3.26	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	151.97	21.41	3.78	0.42	1.26	0.00	1.26	2.10	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	43.12	0.00	0.00	0.00	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	128.59	16.07	5.63	1.61	5.63	0.80	0.00	4.02	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	120.03	25.85	5.54	1.85	2.77	0.92	0.92	1.85	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	118.01	30.21	8.97	1.42	1.89	0.47	3.78	1.89	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	97.05	24.49	2.72	0.00	2.72	0.00	1.81	0.00	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	109.76	31.21	5.38	1.08	3.23	0.00	0.00	2.15	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	127.05	50.82	6.35	0.00	2.54	0.00	1.27	3.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	16.43	0.00	0.00	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	121.16	30.61	6.38	1.28	3.19	0.64	1.91	1.28	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	102.07	29.16	9.11	1.82	7.29	0.00	0.00	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	79.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	141.38	32.85	2.14	0.00	1.43	0.71	1.43	2.86	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	99.55	26.55	3.32	0.00	3.32	0.00	0.00	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	133.65	29.01	5.56	0.93	2.47	0.62	0.62	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	73.75	19.32	3.51	1.76	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	110.01	18.86	12.57	0.00	0.00	0.00	3.14	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	92.49	28.51	4.17	2.09	1.39	0.00	0.70	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	115.08	48.69	6.64	0.00	2.21	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	97.26	22.69	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	146.48	28.77	6.10	1.74	0.87	0.87	1.74	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	137.24	45.00	4.50	2.25	0.00	0.00	2.25	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	114.99	27.88	3.48	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	138.68	42.67	3.20	1.07	2.13	0.00	2.13	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	106.68	24.94	5.54	1.39	4.16	0.00	0.00	1.39	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	105.44	19.95	5.70	0.00	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	125.18	23.01	2.76	0.92	2.76	0.00	1.84	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	121.01	36.30	0.00	0.00	0.00	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	155.22	37.25	6.21	0.00	0.00	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	132.17	33.84	6.34	2.11	1.06	0.00	3.17	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	76.78	18.20	3.92	5.47	1.71	1.96	0.98	0.90	0.00	0.82
Keratinocyte - epidermal, donor2	11349-117G8	89.60	24.01	4.10	1.17	1.76	0.00	0.00	2.34	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	92.10	34.36	7.67	3.79	1.04	0.57	0.38	0.85	0.47	0.09
Keratinocyte - oral, donor1	11251-116E9	114.09	53.35	4.99	10.78	4.31	1.48	4.09	2.50	2.84	0.34
Keratocytes, donor1	11527-119I6	198.05	44.35	9.63	5.16	1.72	2.75	1.03	0.69	0.69	0.00
Keratocytes, donor2	11607-120I5	103.12	48.04	3.52	5.86	8.20	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	91.09	38.73	4.74	4.54	3.36	2.77	1.38	1.38	0.59	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	149.46	114.29	21.98	0.00	0.00	0.00	0.00	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	72.28	37.76	1.08	5.39	1.08	3.24	1.08	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	74.27	52.59	10.84	1.38	0.69	1.73	0.58	1.85	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	49.65	32.69	6.56	1.11	1.61	0.40	0.20	3.43	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	65.93	43.52	4.15	0.71	0.36	0.71	0.47	2.13	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	49.95	34.61	1.67	0.56	0.00	0.84	0.28	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	50.21	32.11	1.89	4.09	0.31	2.99	0.63	0.94	0.16	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	45.17	22.58	2.69	0.54	0.00	0.54	0.00	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.21	34.98	3.47	0.32	0.32	0.63	1.89	2.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	52.72	35.26	3.45	3.99	0.11	2.80	0.97	2.26	0.11	2.16
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	43.50	24.21	0.82	0.82	0.00	0.41	0.82	2.46	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	46.01	36.91	4.80	0.51	0.00	0.76	1.26	2.02	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	52.50	36.17	1.97	4.36	0.00	2.96	1.97	1.69	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	40.34	24.13	2.37	0.40	0.40	0.40	1.19	1.98	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	50.41	38.39	3.30	0.78	0.00	0.39	1.16	2.13	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	59.25	34.44	3.70	2.96	0.19	4.81	0.93	2.59	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	51.92	28.22	2.09	0.35	0.35	0.00	1.39	2.09	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	48.66	30.77	3.10	0.00	0.00	0.24	0.24	3.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	55.63	38.05	2.20	2.61	0.41	3.30	0.82	1.79	0.00	2.06
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	49.27	28.95	2.77	0.00	0.00	0.31	0.92	1.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	44.58	29.30	3.12	0.00	0.00	0.31	1.56	2.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	56.91	33.12	3.66	5.12	0.18	3.66	0.37	2.20	0.37	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	55.29	24.03	2.30	0.33	0.33	0.66	1.32	2.96	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	53.89	26.36	2.64	0.00	0.00	0.59	0.59	2.93	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	59.49	29.87	2.74	3.98	0.00	4.73	1.24	1.49	0.00	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	46.56	27.64	1.94	0.00	0.00	0.97	1.94	2.91	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	44.16	29.08	2.96	0.54	0.00	0.54	0.54	2.96	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	53.28	31.94	2.12	3.78	0.15	4.24	1.21	2.57	0.15	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	45.62	19.70	2.59	0.52	0.52	0.52	0.52	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	43.13	32.66	3.35	0.42	0.00	1.05	0.42	2.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	52.78	34.44	4.21	3.91	0.15	4.06	1.35	2.26	0.00	1.35
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	38.52	28.89	0.69	2.06	0.00	0.69	0.69	2.75	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	41.39	35.56	3.01	0.38	0.00	0.38	0.38	2.82	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	53.12	34.99	3.61	2.86	0.11	1.70	0.95	1.27	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	40.70	29.07	3.39	1.94	0.48	0.97	0.00	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	43.99	31.76	2.32	0.33	0.00	0.00	1.32	1.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	49.31	38.41	2.60	5.08	0.12	1.86	0.37	1.98	0.12	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	51.83	28.14	3.70	0.00	0.00	0.74	0.37	4.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	45.46	31.87	2.22	0.49	0.00	0.99	0.25	1.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	56.37	33.41	2.75	4.12	0.14	2.75	0.14	1.51	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.78	28.95	1.61	0.96	0.00	0.96	0.64	2.89	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	40.78	35.91	2.43	0.00	0.00	0.30	0.91	3.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	45.35	33.59	2.24	3.64	0.14	2.66	0.84	1.54	0.00	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	47.65	28.80	2.49	0.36	0.36	1.42	0.71	2.49	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	45.57	30.06	1.45	0.97	0.00	0.48	0.97	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	56.49	44.04	2.96	4.67	0.47	3.11	1.40	2.18	0.00	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	62.31	29.36	2.15	1.79	0.00	1.07	0.36	4.66	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	35.93	44.75	1.96	0.00	0.33	0.33	0.00	1.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	53.91	33.90	3.30	4.71	0.24	3.53	0.71	3.77	0.00	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	59.03	42.45	2.48	1.11	0.12	0.50	0.62	1.98	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	41.24	38.68	4.10	0.26	0.00	0.26	0.26	4.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	54.60	38.19	4.48	3.28	0.00	1.79	1.19	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	151.82	6.80	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	59.07	15.34	2.30	0.77	2.30	0.77	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	56.41	5.20	2.97	0.00	0.00	0.74	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	67.28	6.77	0.00	0.85	0.42	0.42	0.85	2.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	61.19	11.25	1.41	0.00	1.41	0.00	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	59.77	9.34	2.80	1.87	0.00	0.00	1.87	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	41.74	7.21	1.03	0.52	1.03	1.03	2.06	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	63.04	17.84	0.00	1.19	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	82.11	6.79	2.49	1.13	0.23	0.90	0.00	0.90	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.97	6.40	2.62	1.16	0.87	0.29	1.74	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	42.77	7.65	3.60	0.90	0.90	0.45	0.90	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	81.02	6.77	2.03	1.63	0.41	0.00	0.41	1.49	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	59.57	13.35	3.08	1.54	1.54	0.51	1.54	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.22	12.35	2.82	0.71	1.41	0.35	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	47.97	5.33	0.67	0.00	0.00	2.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	56.54	10.19	3.06	1.53	0.51	2.55	2.04	1.53	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	62.97	12.27	2.93	1.33	1.07	0.53	0.27	1.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	55.93	11.34	2.46	1.13	0.94	0.94	0.94	0.94	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	65.65	10.43	2.45	1.84	0.61	0.61	2.45	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	65.23	11.42	10.60	0.00	0.00	0.82	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	58.72	11.66	3.75	0.83	0.62	0.42	1.25	0.21	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	70.35	7.01	2.52	0.84	1.12	0.28	1.12	1.12	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	71.09	14.42	5.15	0.00	1.03	2.06	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	72.87	9.29	4.64	0.87	1.16	0.58	3.19	1.45	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	55.60	6.88	2.09	0.60	1.20	0.30	0.90	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.58	13.28	2.21	1.11	0.55	0.55	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	62.92	13.79	2.83	1.77	1.41	1.06	1.41	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	64.54	11.06	2.58	0.37	2.21	0.37	0.37	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	64.47	11.51	4.61	0.00	0.00	0.00	1.15	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	74.45	9.21	4.22	0.38	0.77	0.00	2.69	0.38	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	73.03	6.79	4.53	1.70	1.13	1.13	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	65.64	16.41	0.82	0.82	0.00	0.82	0.00	1.64	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	70.49	11.30	2.26	1.36	0.90	0.00	1.81	0.90	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	64.63	4.31	1.44	0.72	0.00	0.00	2.15	0.72	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	40.33	21.66	5.98	0.75	1.49	0.75	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	65.77	10.78	3.34	1.86	1.49	0.00	2.60	1.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	59.01	8.61	2.58	1.29	0.86	0.86	0.00	0.86	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	66.79	17.98	1.71	0.00	0.00	2.57	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	67.30	14.99	3.00	1.00	1.33	0.00	1.33	1.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	76.02	13.27	2.41	3.62	0.00	0.60	1.81	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	78.21	13.51	4.27	2.13	0.71	2.13	1.42	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	68.06	7.91	4.81	0.69	1.03	0.69	3.44	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	67.63	6.44	2.15	2.68	1.07	0.54	1.61	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	76.76	13.47	3.37	0.67	3.37	0.00	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	72.23	7.04	1.11	1.11	0.74	1.11	3.33	1.85	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	154.67	9.30	5.81	1.16	0.00	0.00	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	80.39	11.64	3.17	0.00	1.06	1.06	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	71.23	15.61	1.60	1.20	1.20	2.00	1.20	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	61.78	8.72	2.18	1.45	0.00	0.00	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	59.02	19.93	3.83	0.00	1.53	0.00	1.53	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	70.05	9.87	2.96	0.99	0.49	0.99	3.95	0.49	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	41.40	4.70	0.00	0.94	0.94	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	78.94	15.08	3.02	1.51	1.51	0.50	1.51	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	65.79	13.07	4.96	0.45	0.00	0.90	0.90	2.25	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	72.29	1.72	1.72	0.00	0.00	1.72	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	64.57	16.03	4.01	2.23	0.00	0.45	1.78	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	76.25	8.60	1.96	1.17	1.56	1.96	1.17	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	63.99	7.26	0.00	0.66	0.66	0.00	1.32	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	76.80	14.01	5.19	1.04	1.04	1.04	0.00	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	66.51	6.13	4.38	1.31	0.44	0.00	2.63	1.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	63.74	6.71	0.00	1.68	0.56	1.12	1.12	1.12	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	70.66	11.92	3.53	0.44	2.21	1.32	1.32	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	75.99	12.73	1.16	0.77	0.77	0.39	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	56.21	9.11	1.52	0.00	0.51	0.51	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	73.05	8.65	1.44	0.96	2.40	0.00	1.44	0.48	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	67.58	11.53	4.77	0.80	0.40	0.80	0.40	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	64.41	6.08	2.43	0.00	1.22	1.82	3.04	2.43	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	51.19	1.38	3.46	0.69	0.69	0.00	0.00	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	70.68	9.88	3.80	1.90	1.14	0.38	3.42	1.90	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	62.49	9.30	2.58	1.55	0.00	1.03	1.55	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	52.60	9.67	1.81	1.81	0.60	0.00	0.00	1.21	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	67.82	8.87	4.75	0.32	0.32	0.63	0.63	1.58	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	70.37	8.00	0.53	0.00	0.00	1.07	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	62.06	4.60	2.30	0.00	1.72	0.00	1.72	1.15	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	67.36	10.80	2.57	1.03	2.06	0.51	1.03	2.06	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	64.37	10.61	2.83	0.00	0.00	0.71	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	77.18	11.92	1.70	2.27	1.13	1.70	2.27	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	70.72	13.31	2.50	2.91	1.25	0.83	1.25	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	61.86	7.05	1.57	2.35	1.57	0.78	1.57	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	57.62	7.93	2.92	2.09	1.25	0.00	1.25	0.84	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	69.23	13.94	2.32	2.79	0.93	0.46	0.93	0.93	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	74.93	6.02	1.34	0.67	0.00	0.67	1.34	0.67	0.00	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	80.73	8.55	0.53	2.67	0.00	0.00	1.07	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	77.59	7.68	4.85	1.62	0.81	0.81	1.62	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	81.68	7.34	0.92	0.92	0.00	0.92	1.84	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	68.46	5.33	3.56	0.00	2.67	0.00	3.56	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	81.49	14.82	1.71	1.71	1.71	1.14	1.71	2.85	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	85.89	5.37	1.53	0.77	1.53	0.77	1.53	1.53	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	76.60	3.28	2.19	3.28	1.64	1.09	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	93.10	11.14	4.45	2.23	0.45	0.45	1.78	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	105.28	9.62	3.90	2.34	0.78	1.56	0.26	2.08	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	78.25	4.64	5.30	0.66	1.99	0.00	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	124.72	22.86	8.31	0.00	0.00	4.16	4.16	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	56.52	12.76	6.38	4.56	0.00	1.14	0.00	0.23	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	69.55	28.44	8.44	25.69	0.00	2.02	0.00	0.18	0.00	5.51
Macrophage - monocyte derived, donor3	11389-118C3	65.67	27.79	6.29	2.23	0.00	1.70	0.92	0.66	0.00	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	51.51	31.33	5.31	5.84	4.78	0.53	0.53	2.12	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	66.23	26.46	3.80	3.49	1.11	2.06	1.43	1.58	0.00	0.79
Mallassez-derived cells, donor3	11930-125I4	73.11	22.79	3.61	4.31	1.53	0.83	0.28	0.97	0.42	0.42
Mammary Epithelial Cell, donor1	11273-116H4	80.61	22.12	3.99	2.09	1.49	0.90	0.20	0.60	0.00	0.50
Mammary Epithelial Cell, donor2	11350-117G9	87.15	24.61	4.63	2.90	0.29	0.29	0.29	1.45	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	107.00	42.40	9.73	3.74	1.00	0.75	1.25	1.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	15.59	25.76	2.03	0.68	0.68	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	81.54	39.58	7.03	1.95	0.65	0.65	1.73	1.30	0.32	0.54
Mast cell, donor2	11565-120D8	138.78	38.34	12.78	0.30	1.19	2.38	7.73	1.78	0.00	0.59
Mast cell, donor3	11566-120D9	173.80	41.87	14.41	2.03	4.05	1.13	8.33	4.28	0.23	1.58
Mast cell, donor4	11567-120E1	154.77	36.17	19.15	2.84	0.53	2.30	5.32	2.30	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	67.53	13.53	2.55	9.20	0.11	2.33	2.11	0.22	0.11	2.44
Mast cell, expanded and stimulated, donor8	11942-126A7	51.36	16.93	1.17	3.50	0.00	1.17	3.50	0.58	0.58	2.33
Mast cell, expanded, donor5	11939-126A4	104.86	25.35	4.24	8.03	0.57	3.56	3.67	0.92	0.00	2.75
Mast cell, expanded, donor8	11941-126A6	97.58	36.65	6.36	6.03	4.02	2.34	4.02	1.17	0.33	3.68
Melanocyte - dark, donor1	11502-119F8	80.10	58.01	7.36	3.98	0.70	3.18	0.60	3.08	0.00	0.60
Melanocyte - dark, donor2	11582-120F7	65.76	38.42	5.54	2.77	3.81	1.38	1.38	2.08	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	70.77	35.79	7.39	11.88	2.03	2.97	0.29	1.16	0.36	1.30
Melanocyte - light, donor1	11274-116H5	86.74	40.20	6.58	19.51	3.06	4.70	1.41	2.35	0.47	2.35
Melanocyte - light, donor2	11351-117H1	102.37	37.54	7.51	15.01	0.00	4.09	4.78	1.36	0.00	0.68
Melanocyte - light, donor3	11423-118G1	77.18	44.23	5.20	7.81	2.60	0.87	1.73	1.73	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	83.51	41.55	5.73	8.12	2.08	2.81	1.25	1.15	0.31	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	59.17	38.19	5.11	25.28	0.81	3.50	1.08	1.61	0.81	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	76.34	45.80	7.23	6.16	4.82	2.68	1.07	2.95	0.27	0.54
Meningeal Cells, donor1	11493-119E8	83.49	34.98	6.45	2.36	0.74	2.11	0.62	1.61	0.50	0.37
Meningeal Cells, donor2	11573-120E7	50.62	43.57	10.12	0.88	0.00	0.00	0.44	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	46.54	28.69	4.56	2.28	0.98	0.73	0.16	1.39	0.08	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	67.01	42.77	6.56	3.42	2.85	2.00	0.86	2.57	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	90.87	22.64	5.13	2.72	0.70	1.11	0.70	2.42	0.20	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	215.52	53.88	18.40	1.31	7.88	7.88	2.63	3.94	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	81.11	19.62	3.92	3.92	9.16	2.62	1.31	2.62	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	64.58	22.96	6.46	4.31	2.15	2.15	1.44	2.15	0.00	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	89.15	43.20	7.20	4.02	3.81	4.24	2.33	2.54	1.48	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	95.50	55.29	7.04	4.02	6.53	2.01	3.02	1.51	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	43.29	32.52	4.40	2.20	1.98	1.10	0.00	1.10	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	69.41	56.99	3.65	3.65	2.19	3.65	0.73	2.92	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	55.86	42.56	5.93	2.86	2.05	1.23	0.82	1.43	1.02	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	52.91	14.82	4.29	0.69	0.97	0.83	1.11	2.35	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	163.19	47.95	10.41	2.60	3.72	4.46	2.60	2.60	1.86	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	107.63	34.34	6.97	0.79	2.63	1.97	0.66	2.24	1.18	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	83.98	39.76	8.61	1.48	2.97	2.08	0.59	2.08	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	63.06	42.04	7.01	0.00	0.00	0.00	4.67	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	78.77	61.48	8.33	6.40	3.84	2.56	0.00	1.92	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	55.65	14.18	5.32	3.19	1.06	1.06	0.00	0.35	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	106.01	31.59	7.19	1.88	1.56	1.56	1.56	1.25	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	49.35	59.51	5.81	1.45	1.45	2.90	0.73	0.73	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	115.88	32.88	9.81	5.57	2.39	1.33	0.80	3.98	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	210.20	34.53	14.51	6.01	1.00	0.00	2.00	4.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	73.49	50.51	7.52	6.58	2.24	0.87	0.58	3.54	0.29	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	128.28	18.90	12.15	6.75	0.00	4.05	0.00	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	109.10	28.57	7.63	10.34	0.99	2.46	1.23	0.25	0.00	3.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	120.73	41.81	7.66	32.10	0.88	5.30	0.59	0.00	0.29	10.89
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	17.29	3.46	3.46	0.00	0.00	0.00	0.00	0.00	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	65.40	18.60	5.27	7.75	0.00	2.17	0.93	0.00	0.00	2.48
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	93.55	25.51	2.70	23.65	1.04	4.77	1.45	0.00	0.21	7.05
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	11.58	0.00	2.32	0.00	0.00	0.00	0.00	0.00	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	103.11	23.52	10.01	15.02	0.75	1.25	0.50	1.00	0.00	3.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	111.72	26.53	6.52	22.81	1.40	4.65	0.93	0.47	0.00	9.31
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	95.10	22.76	4.47	10.57	0.81	1.83	1.02	0.41	0.20	3.66
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	101.76	31.28	3.17	32.47	1.19	3.96	1.58	0.79	0.00	6.34
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	42.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	56.64	8.85	2.65	4.42	1.77	0.00	1.77	0.88	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	117.40	25.84	6.46	38.37	0.38	5.32	1.90	0.00	0.00	9.50
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	38.16	23.69	3.95	1.32	0.00	1.32	0.00	0.00	0.00	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	61.55	14.64	3.82	7.64	0.42	2.33	1.91	0.21	0.21	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	46.96	26.70	1.84	11.97	1.84	1.84	0.00	0.00	0.00	5.52
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	56.63	14.01	4.17	5.96	0.30	0.60	0.30	0.30	0.00	2.38
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	82.16	25.15	5.03	3.35	3.35	0.00	0.00	0.00	0.00	5.03
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	60.47	12.04	5.27	6.02	0.00	2.26	1.76	0.50	0.25	2.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	91.50	30.66	4.04	26.62	1.19	3.80	0.24	0.71	0.95	8.79
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	30.96	8.29	3.32	3.32	0.55	2.21	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	60.55	12.89	4.37	7.37	0.23	1.38	0.92	0.00	0.00	3.68
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	101.17	27.55	5.89	22.51	1.68	3.79	1.26	0.42	0.00	8.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	46.47	20.38	4.89	4.89	0.41	2.24	0.82	0.20	0.20	3.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	62.43	12.66	3.86	9.01	0.21	1.50	0.64	0.21	0.21	2.79
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	75.36	30.68	4.67	18.23	1.11	2.00	0.22	0.67	0.00	6.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	49.72	13.14	1.97	6.35	0.44	1.97	0.66	0.22	0.00	2.85
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	74.02	26.36	7.10	13.18	1.52	2.03	0.00	0.51	0.00	7.10
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	9.94	0.00	3.31	0.00	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	58.44	14.40	3.53	5.16	0.00	1.36	0.82	0.27	0.27	2.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	97.34	24.70	6.76	19.70	1.47	2.65	0.88	0.88	0.00	11.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	45.79	10.90	3.27	4.36	2.18	0.00	0.00	0.00	1.09	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	63.91	16.34	2.88	8.17	0.96	1.44	0.00	0.48	0.48	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	99.66	26.01	6.40	30.42	2.00	4.00	2.40	0.40	0.40	11.61
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	16.45	4.11	5.48	2.74	1.37	0.00	0.00	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	78.59	12.51	3.50	7.01	1.00	0.00	0.50	0.00	0.00	3.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	26.95	0.00	0.00	26.95	0.00	0.00	0.00	0.00	53.89
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	20.39	2.04	4.08	0.00	2.04	0.00	0.00	0.00	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	67.88	12.26	1.75	6.57	0.00	0.88	0.00	0.00	0.00	4.38
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	90.50	38.63	12.14	5.52	4.41	5.52	0.00	0.00	1.10	7.73
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	39.70	30.10	3.84	1.28	0.64	1.92	0.00	0.00	0.00	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	72.39	16.61	6.20	6.94	0.99	1.98	0.74	0.25	0.50	5.21
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	81.42	31.32	10.44	8.35	2.78	2.09	0.70	0.00	0.70	8.35
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	68.51	22.10	4.42	4.42	0.00	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	82.73	19.83	4.44	8.21	2.05	1.37	3.08	0.68	1.03	5.81
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	98.46	50.76	6.56	12.25	6.56	5.25	0.88	0.00	1.31	17.50
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	58.59	27.34	6.39	3.55	2.13	1.78	0.36	0.71	0.00	4.62
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	91.74	20.20	2.24	7.86	2.24	1.96	5.05	0.00	0.00	6.17
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	110.97	46.55	9.56	14.96	5.40	7.90	0.42	0.83	0.83	14.13
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	71.10	32.05	3.50	2.91	5.83	1.75	0.00	0.58	0.00	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	82.05	23.83	4.83	7.84	3.62	1.51	1.21	0.30	0.60	6.03
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	133.15	52.59	5.43	29.63	7.93	5.01	4.17	0.42	2.50	17.95
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	28.88	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	74.81	18.47	5.54	7.39	4.62	2.77	0.92	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	113.82	51.22	10.81	18.78	7.97	3.98	1.14	0.57	0.57	23.33
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	70.20	28.88	6.22	6.49	3.32	1.80	0.55	0.69	0.69	5.94
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	97.96	22.55	4.92	12.96	2.85	2.07	2.85	0.26	0.52	9.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	104.67	57.48	9.01	18.02	10.30	5.15	1.29	0.43	1.72	23.59
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	47.64	26.68	2.54	3.18	4.45	0.00	0.00	0.00	0.00	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	79.27	18.95	3.74	5.34	1.60	2.40	0.27	1.33	1.07	4.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	112.55	41.91	10.18	20.06	4.79	3.59	1.20	0.60	2.10	15.27
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	48.59	19.63	4.52	3.11	2.12	0.57	0.14	0.57	0.28	2.68
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	80.27	17.20	3.50	13.06	2.23	1.91	3.19	0.96	2.23	6.05
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	127.81	66.78	9.95	28.30	10.39	4.86	1.55	0.66	1.99	19.90
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	56.50	28.06	4.17	4.55	3.03	1.90	0.76	0.38	0.00	5.31
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	82.67	11.93	3.98	10.80	3.41	2.27	0.57	0.85	0.00	3.13
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	123.64	51.62	9.09	28.02	5.65	5.65	4.42	0.25	1.23	20.89
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	43.66	18.90	3.26	1.96	1.30	0.65	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	60.28	19.41	2.65	9.11	1.47	1.18	0.88	0.29	0.29	3.82
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	116.48	38.06	6.34	26.81	4.32	3.46	0.86	0.58	0.58	12.40
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	64.29	11.54	7.01	6.18	0.00	0.41	0.41	0.82	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	64.62	11.02	5.96	7.15	1.49	1.79	0.89	0.00	0.00	3.87
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	52.74	3.77	3.77	0.00	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	60.60	17.82	5.35	8.91	1.78	1.78	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	78.53	23.66	9.20	6.24	0.00	1.64	0.66	0.00	0.00	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	57.86	25.25	4.21	10.52	0.00	0.00	2.10	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	81.84	11.07	6.52	9.69	0.00	0.20	0.59	0.59	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	75.44	20.49	13.97	13.97	2.79	0.00	1.86	0.00	0.00	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	52.95	26.66	3.76	6.01	0.75	2.25	0.75	0.00	0.00	3.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	78.84	26.37	5.86	13.32	0.00	0.80	0.53	0.00	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	58.02	5.88	3.05	5.09	0.11	1.02	0.34	0.00	0.00	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	48.62	21.37	10.31	10.31	0.74	2.21	0.00	0.00	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	71.09	19.79	4.03	7.69	0.00	2.93	0.37	0.37	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	10.89	1.56	6.22	0.00	0.00	6.22	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	57.18	5.88	2.14	3.74	0.53	0.53	0.00	0.53	0.00	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	73.41	27.05	3.86	15.46	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	67.67	25.25	8.08	4.04	0.00	1.01	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	54.81	18.55	5.90	5.06	0.84	1.26	0.42	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	2.72	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	35.60	5.09	1.27	10.17	0.00	0.00	0.64	0.00	0.00	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	14.58	3.24	0.00	4.05	0.00	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	15.10	4.53	1.51	1.51	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	0.00	5.71	5.71	0.00	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	16.31	19.57	22.84	0.00	13.05	0.00	3.26	0.00	19.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	76.04	0.00	4.75	9.50	0.00	4.75	9.50	0.00	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	75.29	12.55	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	54.07	29.51	4.74	2.80	1.08	1.72	1.08	1.94	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	47.56	33.97	5.23	2.61	1.05	0.52	0.52	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	38.05	97.45	11.35	4.00	6.01	1.33	0.67	2.00	0.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	36.73	187.82	25.88	8.35	3.76	2.50	0.42	2.09	0.42	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	100.01	56.28	11.98	7.23	3.42	0.57	0.76	2.09	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	70.22	137.24	19.15	1.60	11.17	1.60	0.00	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	23.12	97.91	7.48	2.04	4.76	2.72	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	1.84	0.00	5.51	0.00	1.84	1.84	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.62	112.17	11.30	1.67	7.95	3.77	1.26	1.26	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	48.11	157.59	21.15	7.90	4.42	2.32	0.70	2.32	0.23	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	29.18	138.09	16.48	3.78	5.67	3.24	1.89	1.08	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	46.67	47.93	11.56	1.89	1.47	0.84	0.21	0.63	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.28	55.10	8.93	5.46	3.47	1.49	0.99	1.49	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	57.92	46.83	11.91	2.17	2.44	0.27	0.27	1.62	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.79	107.90	13.60	4.76	3.40	2.49	1.59	2.95	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	26.78	104.68	13.23	1.47	4.90	1.47	0.49	1.14	0.16	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	33.35	39.37	8.20	1.09	1.09	0.73	1.28	0.91	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.40	74.79	5.30	6.37	2.65	1.59	1.06	0.53	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	91.85	5.40	3.00	6.00	1.20	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	56.77	19.03	3.61	2.30	1.31	0.33	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.16	107.49	17.73	2.11	2.44	3.09	0.49	1.30	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	35.10	46.92	8.47	1.06	1.23	0.71	0.53	0.88	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	80.17	7.74	1.41	4.92	2.11	0.70	2.11	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	32.18	131.48	14.71	3.22	4.14	0.92	0.00	0.92	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.21	131.43	16.39	1.61	4.82	2.89	1.61	1.61	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	51.04	22.76	7.59	4.14	1.03	0.69	0.69	1.03	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	15.17	2.53	0.00	2.53	0.00	0.00	10.11	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	27.40	45.67	8.47	1.11	1.11	1.78	0.67	1.34	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	29.64	108.81	10.58	2.96	2.12	0.85	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	53.17	73.10	13.53	3.09	4.98	0.71	0.24	1.66	0.00	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.18	138.65	11.16	1.72	4.72	1.29	1.29	0.86	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	18.06	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.32	104.96	13.66	0.33	1.33	2.33	0.67	0.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	29.31	47.79	7.66	0.90	0.45	0.45	0.45	1.35	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.63	55.55	10.71	1.59	3.57	1.19	1.19	0.79	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	87.29	11.14	1.86	3.71	5.57	0.00	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	36.70	103.30	16.65	2.27	3.78	1.51	0.38	0.76	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.16	99.40	13.04	5.21	0.98	4.89	0.65	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.92	91.95	10.46	1.74	3.49	3.49	0.44	2.18	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.37	46.13	8.14	1.81	0.00	0.90	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	77.61	9.70	3.53	3.53	5.29	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.28	102.39	7.31	2.66	1.33	5.32	1.33	0.00	0.66	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	26.29	109.63	9.92	0.99	2.98	3.97	0.99	2.48	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	18.38	113.70	11.10	3.06	0.38	2.68	0.38	1.15	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.06	30.24	7.26	2.12	1.51	1.81	0.00	1.21	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	40.45	27.85	5.97	1.99	0.22	1.55	0.00	0.88	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.04	88.77	6.78	4.74	0.68	2.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	0.00	0.00	0.00	0.00	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.24	96.33	7.93	0.61	1.22	1.83	0.00	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	32.10	121.17	18.25	2.20	0.63	1.57	0.00	1.57	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.94	86.26	11.50	1.82	1.21	2.72	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	36.39	56.17	6.33	2.37	1.58	1.58	1.58	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	60.08	18.14	4.53	6.80	0.00	0.00	2.27	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	0.00	0.00	0.00	0.00	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	64.85	20.62	3.23	4.47	1.99	1.61	1.99	1.61	0.50	1.12
Myoblast, donor2	11322-117D8	68.85	37.02	7.48	5.18	3.45	4.22	2.69	0.77	0.58	0.96
Myoblast, donor3	11398-118D3	51.29	39.35	6.05	4.04	1.85	2.19	0.84	1.68	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	98.65	75.45	6.71	3.94	5.69	0.29	1.31	0.15	0.44	0.58
Natural Killer Cells, donor1	11230-116C6	218.95	187.89	13.22	8.30	39.05	2.77	7.69	0.62	14.45	6.15
Natural Killer Cells, donor2	11311-117C6	196.01	346.19	15.98	2.11	75.09	0.60	13.57	0.00	25.03	3.32
Natural Killer Cells, donor3	11387-118C1	183.13	344.55	16.75	9.02	59.45	3.68	7.36	1.29	18.04	7.36
Neural stem cells, donor1	11275-116H6	52.99	27.22	2.18	3.99	0.36	2.54	2.54	2.90	1.81	0.00
Neural stem cells, donor2	11352-117H2	103.98	63.55	7.70	1.93	0.00	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	193.44	141.10	11.38	6.83	4.55	4.55	7.97	0.00	0.00	1.14
Neurons, donor2	11574-120E8	165.56	77.50	13.65	8.59	1.76	1.98	1.10	2.86	0.44	0.88
Neurons, donor3	11655-122E8	191.56	270.49	24.66	10.69	10.69	4.93	9.04	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	12.06	5.57	0.93	0.00	1.86	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	28.99	11.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	9.16	13.44	0.61	0.00	1.83	0.00	0.61	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	106.03	41.68	7.12	2.26	4.75	2.61	2.97	2.97	2.61	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	98.66	121.78	8.14	6.51	8.47	5.54	1.63	2.93	2.28	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	75.81	38.51	6.22	1.60	3.61	1.80	1.20	2.01	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	91.81	106.68	14.04	3.17	17.07	3.85	2.06	3.85	1.10	0.28
Olfactory epithelial cells, donor2	11934-125I8	104.07	93.36	12.88	6.95	12.01	3.33	2.89	2.46	1.01	0.72
Olfactory epithelial cells, donor3	11935-125I9	99.20	80.93	11.46	7.83	8.63	3.18	1.59	2.50	0.23	1.02
Olfactory epithelial cells, donor4	11936-126A1	129.44	53.37	9.84	4.68	10.71	3.70	1.07	1.56	0.58	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	108.33	60.78	9.63	4.81	2.41	2.41	0.00	0.60	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	84.65	34.88	6.17	1.49	1.28	1.06	2.13	3.19	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	78.87	33.15	8.00	1.14	2.29	1.14	5.72	4.57	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	50.28	47.17	8.69	3.10	2.48	1.24	1.86	1.24	0.62	0.00
Osteoblast, donor1	11277-116H8	122.15	56.68	12.12	4.10	2.74	1.17	2.15	4.30	0.98	0.59
Osteoblast, donor2	11354-117H4	52.67	32.31	7.02	0.00	2.11	1.40	1.40	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	118.55	58.65	10.49	2.31	2.49	0.53	2.31	2.67	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	64.86	20.47	6.49	2.53	3.37	2.19	1.68	1.43	0.59	0.59
Pericytes, donor1	11491-119E6	123.06	37.50	11.24	5.67	2.45	3.23	1.22	3.23	0.78	0.33
Pericytes, donor2	11571-120E5	97.56	63.16	12.68	1.36	3.17	1.58	2.26	2.72	1.58	0.45
Pericytes, donor3	11652-122E5	77.51	58.39	9.36	1.02	3.46	2.03	1.42	1.63	1.63	0.00
Perineurial Cells, donor1	11499-119F5	50.97	42.16	7.57	3.73	1.13	1.13	0.23	1.81	0.23	0.11
Perineurial Cells, donor2	11579-120F4	68.00	47.29	8.47	1.38	3.68	2.48	0.46	1.56	0.92	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	149.81	132.28	7.01	6.69	45.90	3.51	4.46	1.59	14.66	4.14
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	116.06	137.37	7.35	9.55	32.08	2.20	5.14	0.73	7.59	8.33
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	123.20	210.30	7.64	2.20	45.17	0.52	6.47	1.04	14.49	0.26
Placental Epithelial Cells, donor1	11278-116H9	42.81	17.94	6.22	1.91	0.24	0.24	0.00	0.96	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	39.92	16.63	3.33	4.44	1.11	0.00	2.22	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	41.23	35.34	8.83	1.96	2.16	0.59	1.37	1.18	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	88.92	42.09	6.65	8.54	5.70	3.80	4.11	1.90	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	96.80	16.51	4.88	3.75	3.75	1.88	1.31	1.69	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	41.12	7.57	3.79	3.13	0.26	1.44	0.26	1.83	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	102.22	41.43	9.68	5.85	3.60	1.35	4.05	2.03	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	109.65	25.36	7.99	5.43	2.88	1.28	2.24	1.81	0.64	0.00
Preadipocyte - omental, donor2	11329-117E6	99.52	43.65	9.60	5.24	3.06	1.31	1.31	6.11	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	74.35	55.87	10.89	3.15	3.44	1.43	2.15	2.58	0.29	0.43
Preadipocyte - perirenal, donor1	11469-119C2	121.06	34.45	8.86	2.95	7.87	0.00	2.95	3.94	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	104.11	27.33	9.52	5.22	1.84	1.84	1.54	1.23	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	59.50	30.10	9.74	3.19	3.19	1.24	1.24	1.24	0.18	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	65.90	36.95	11.75	2.04	3.41	1.53	2.72	1.53	0.85	0.17
Preadipocyte - visceral, donor1	11280-116I2	50.95	20.96	7.27	6.05	2.89	0.84	0.84	1.40	0.47	0.65
Preadipocyte - visceral, donor2	11357-117H7	63.50	41.88	8.28	7.36	3.22	2.76	0.92	1.84	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	39.29	28.73	8.05	4.70	2.82	1.25	1.57	0.84	0.84	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	90.06	23.68	3.17	0.30	0.30	0.00	4.22	0.45	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	84.50	50.64	6.23	5.69	3.52	2.98	6.64	2.17	1.35	0.68
Prostate Epithelial Cells, donor3	11404-118D9	78.20	45.38	4.53	3.00	1.29	0.43	2.08	0.43	0.18	0.31
Prostate Stromal Cells, donor1	11254-116F3	59.46	20.62	4.10	1.71	2.39	1.48	1.59	0.68	0.57	0.11
Prostate Stromal Cells, donor2	11332-117E9	51.46	39.27	8.61	2.69	2.69	2.33	2.15	0.72	1.26	0.18
Prostate Stromal Cells, donor3	11405-118E1	89.36	47.97	11.05	2.19	3.86	1.98	3.96	2.50	0.83	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	91.25	45.26	6.20	6.20	1.46	1.46	1.09	2.55	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	61.20	25.37	2.15	5.96	1.18	1.04	0.21	1.94	0.00	0.49
Renal Epithelial Cells, donor1	11517-119H5	118.18	58.84	7.10	2.54	1.01	2.03	1.01	4.57	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	108.12	91.05	10.67	9.25	0.71	4.27	1.42	2.13	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	84.48	30.17	2.96	4.23	0.53	0.85	0.85	2.65	0.42	1.16
Renal Glomerular Endothelial Cells, donor1	11514-119H2	76.94	74.21	3.40	2.04	2.04	2.72	2.04	6.13	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	74.66	73.85	5.66	7.82	2.29	4.18	0.81	3.64	0.81	2.29
Renal Glomerular Endothelial Cells, donor3	11675-122H1	64.16	75.71	4.66	2.22	2.44	3.33	0.89	2.00	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	113.13	65.88	3.99	1.33	0.00	7.32	0.67	6.65	0.00	3.33
Renal Mesangial Cells, donor1	11518-119H6	84.95	45.56	10.34	5.06	4.18	2.86	3.08	0.88	1.32	0.88
Renal Mesangial Cells, donor2	11598-120H5	121.01	71.48	12.54	5.02	1.25	1.25	1.25	2.51	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	111.80	78.51	8.04	5.55	1.39	4.16	1.11	1.94	1.11	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	93.95	34.09	6.98	6.17	0.54	0.81	0.81	1.88	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	92.77	36.69	5.48	4.64	1.69	1.27	1.27	2.11	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	103.94	73.09	6.75	5.40	3.66	2.12	0.77	5.01	0.39	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	73.12	33.45	7.78	9.33	0.26	3.11	0.26	1.81	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	72.20	29.28	4.55	1.99	0.57	2.27	0.57	0.85	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	87.48	27.79	3.09	2.06	0.00	5.15	3.09	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	69.25	10.29	0.50	3.26	0.00	1.51	0.75	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	188.43	36.22	9.89	11.76	2.14	6.28	2.81	1.74	1.20	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	95.59	11.61	0.00	5.36	0.00	2.68	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	55.04	4.95	0.00	6.60	1.10	1.10	1.10	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	91.65	9.86	0.00	3.48	1.74	0.00	2.32	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.27	11.44	1.95	1.56	1.17	1.95	0.26	1.43	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.58	31.38	3.67	3.67	0.70	1.69	1.19	1.69	0.20	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	75.29	18.40	3.01	4.24	0.45	1.45	0.00	1.00	0.33	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	53.46	16.75	1.74	2.85	0.25	0.87	0.25	1.61	0.37	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	67.25	30.07	3.61	2.80	0.70	1.05	1.05	1.75	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	66.33	30.28	3.24	4.39	0.69	1.85	0.46	1.39	0.23	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	53.81	19.44	2.74	1.51	0.55	2.05	0.41	0.27	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	54.00	24.20	3.03	3.63	0.61	0.76	0.45	1.36	0.30	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	69.88	20.79	4.84	3.40	0.72	1.43	0.36	1.61	0.18	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	53.22	17.50	1.86	2.73	0.72	2.15	0.29	0.72	0.14	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	60.53	26.08	3.76	3.86	0.21	0.97	0.86	1.29	0.32	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	66.38	37.17	3.32	4.43	0.44	2.43	0.44	1.99	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	39.19	17.01	2.49	0.96	0.96	1.34	0.00	0.96	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	54.97	31.02	3.07	2.98	0.56	1.86	0.37	1.12	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	71.59	14.66	3.76	4.51	0.00	1.88	0.38	0.56	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	54.94	24.55	2.65	1.33	1.06	1.19	0.40	1.73	0.13	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	49.84	29.40	4.58	2.24	0.58	1.07	0.29	2.14	0.19	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	62.06	30.17	2.48	5.16	0.76	2.67	0.38	1.15	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.25	18.80	2.35	2.03	0.64	1.28	0.32	0.64	0.21	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	47.65	25.79	4.20	3.08	1.40	0.84	0.84	1.40	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	61.52	31.27	3.76	4.10	1.20	1.54	0.51	0.85	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.74	18.23	2.01	1.09	0.91	0.91	0.36	1.09	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	54.33	33.72	4.41	4.17	0.49	1.72	0.98	1.47	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	68.77	31.97	5.51	3.36	0.40	1.88	1.07	0.54	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	45.05	10.38	1.42	1.65	0.94	1.89	0.94	0.94	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	63.69	33.73	2.98	2.78	1.79	1.59	0.99	1.39	0.00	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	73.43	38.82	5.14	3.74	1.64	0.94	0.23	0.47	0.23	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	47.28	25.30	2.28	2.28	0.41	2.28	1.04	1.04	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	63.27	19.91	2.88	3.32	1.55	2.88	1.77	1.33	0.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	56.82	44.49	4.18	3.13	1.25	2.30	0.63	1.46	0.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	48.32	24.63	3.10	2.42	0.54	1.75	0.67	1.35	0.27	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	48.70	37.98	3.92	1.87	0.51	1.19	0.17	1.19	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	59.77	40.68	4.63	2.51	0.77	1.74	0.58	0.77	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	39.37	14.27	1.38	2.58	0.69	2.24	0.34	0.52	0.17	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	47.46	39.64	5.08	2.19	0.82	1.51	0.14	1.65	0.14	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	53.19	29.88	5.75	3.61	0.49	1.48	0.82	1.15	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	44.82	18.75	2.22	1.70	0.51	1.53	1.02	0.34	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	58.89	39.65	5.03	3.70	0.44	1.63	0.59	1.33	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	62.37	47.98	3.47	2.40	0.27	2.13	0.27	0.80	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	62.77	17.28	2.35	0.97	0.97	1.11	0.55	1.66	0.28	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	66.19	33.10	4.52	2.86	0.48	2.38	1.19	1.19	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	70.94	43.53	4.64	2.22	2.22	0.60	0.60	1.61	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	63.76	16.39	3.67	1.70	0.38	0.94	1.60	1.04	0.19	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	76.16	24.46	4.54	3.84	0.70	1.40	1.75	0.35	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	64.37	39.29	5.14	2.42	0.60	1.51	0.60	2.12	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	60.21	18.48	4.28	3.06	0.73	0.98	0.98	0.86	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	87.33	19.36	2.62	4.37	0.15	0.87	0.44	1.31	0.58	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	97.35	29.20	4.26	7.91	0.61	1.83	1.22	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	58.77	15.97	1.81	2.41	0.30	1.21	0.90	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	73.74	23.75	4.07	3.85	0.45	0.68	2.26	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	103.64	33.55	3.29	5.69	0.30	0.90	0.90	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	75.10	13.46	2.48	2.83	0.35	0.59	2.13	1.42	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	106.08	30.31	2.56	2.77	0.21	1.07	6.19	1.49	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	149.04	31.25	4.21	3.61	0.60	0.00	0.60	1.20	0.60	1.20
Schwann Cells, donor1	11498-119F4	91.40	88.77	11.47	3.20	1.50	1.50	1.32	3.01	0.38	0.38
Schwann Cells, donor2	11578-120F3	51.04	44.23	3.40	0.00	6.80	3.40	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	62.22	60.25	7.01	3.72	4.60	3.07	1.53	2.19	0.22	0.66
Sebocyte, donor1	11220-116B5	66.28	32.87	7.67	0.55	0.55	1.10	0.55	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	65.26	34.01	5.97	5.06	2.30	0.92	1.38	0.00	0.00	1.38
Sebocyte, donor3	11378-118B1	83.68	35.66	6.80	4.33	2.06	3.30	1.24	1.65	0.41	0.21
Sertoli Cells, donor1	11255-116F4	124.24	33.13	6.63	3.31	1.66	3.31	0.00	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	93.20	19.77	2.82	0.00	5.65	0.00	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	98.71	26.31	5.89	2.55	1.67	0.97	1.41	2.64	1.14	0.18
Skeletal Muscle Cells, donor2	11358-117H8	96.86	31.81	6.51	2.89	0.72	0.00	1.45	2.17	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	128.75	59.36	11.70	3.34	1.67	0.00	0.84	2.51	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	28.59	18.38	3.93	1.41	1.26	0.79	1.26	0.63	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	30.77	21.55	4.61	2.08	1.34	1.93	1.34	0.45	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	41.40	30.93	5.54	2.15	1.54	1.85	1.23	0.77	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	56.70	24.82	9.45	1.76	3.28	0.76	1.26	2.02	1.76	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	58.07	39.81	4.99	2.85	3.42	2.28	2.43	2.14	1.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.70	42.07	6.15	3.87	1.59	0.89	1.19	0.79	0.30	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	65.97	19.38	5.31	3.62	0.84	0.59	0.67	0.76	0.76	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	159.23	69.48	16.65	5.79	5.07	0.72	1.45	3.62	4.34	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	75.68	55.87	14.31	1.65	2.89	1.24	2.89	1.65	1.51	0.00
Skin - palm, donor1	10286-104F7	10.74	72.52	5.37	8.06	13.43	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	65.74	34.17	4.76	4.90	1.59	1.44	1.44	0.58	0.29	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	130.86	12.27	0.00	5.73	0.00	0.82	0.82	4.09	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	60.76	42.84	5.71	2.34	2.21	0.52	2.86	0.91	0.91	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	92.44	33.50	3.20	3.89	1.25	0.42	2.36	1.67	0.28	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	74.41	56.83	5.63	2.39	1.83	0.98	1.97	1.27	0.42	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	124.75	34.25	6.34	3.81	1.06	1.90	1.06	3.81	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	92.34	48.27	4.42	1.50	0.97	0.45	1.12	1.42	0.15	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	104.61	37.03	4.63	3.70	3.70	2.16	3.70	1.54	1.23	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	40.02	7.78	2.00	0.44	1.33	1.11	0.89	1.11	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	156.36	43.50	17.05	7.05	6.47	4.11	1.76	3.53	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	94.14	52.37	9.28	5.30	10.17	1.99	1.77	2.87	4.20	1.55
Smooth Muscle Cells - Aortic, donor2	11360-117I1	135.46	41.74	16.14	2.76	3.15	1.18	1.58	2.76	1.18	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	154.51	43.26	16.22	1.55	6.18	2.32	2.32	2.32	3.09	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	68.05	33.02	7.01	0.00	5.00	1.00	4.00	2.00	1.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	143.99	47.77	13.84	4.26	3.59	2.00	1.33	4.92	0.80	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	53.86	38.57	7.09	5.54	3.77	4.21	1.99	2.66	0.22	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	122.14	35.08	9.47	2.56	2.94	1.15	1.54	3.58	0.13	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	65.77	29.63	5.86	6.19	0.98	2.28	0.98	2.28	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	58.18	43.71	10.93	2.66	0.59	1.48	0.59	3.25	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	64.49	46.98	6.69	0.71	4.41	1.00	0.71	1.28	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	99.23	32.70	6.18	3.74	2.44	2.60	0.16	2.44	1.30	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	73.98	29.53	5.18	0.91	5.78	1.83	0.61	1.83	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	111.63	20.96	10.36	1.52	2.78	1.01	1.26	1.77	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	183.62	36.72	6.12	0.00	6.12	6.12	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	139.71	58.17	9.54	4.77	6.20	0.95	5.25	1.43	2.38	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	51.62	16.52	5.16	2.65	0.74	1.03	0.88	0.74	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	47.35	35.73	6.89	1.29	2.80	2.37	0.43	1.29	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	49.44	42.82	6.19	1.99	2.73	1.47	0.94	1.26	0.42	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	152.20	47.95	13.61	2.63	4.64	1.24	1.39	4.02	0.93	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	122.88	66.83	6.47	3.23	0.00	6.47	2.16	3.23	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	92.94	41.84	6.28	3.29	5.08	1.20	1.79	2.99	0.60	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	103.79	53.26	7.17	3.41	5.12	3.07	1.02	2.39	1.37	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	85.20	29.21	4.48	2.12	6.36	2.28	1.41	2.43	1.81	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	82.02	21.64	5.23	4.23	0.70	2.11	3.32	3.62	0.00	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	109.91	93.75	9.78	9.10	8.42	3.87	2.50	3.19	2.05	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	149.75	44.08	9.06	3.02	7.25	1.81	2.42	4.23	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	47.42	33.38	7.68	2.12	4.50	2.12	0.53	0.53	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	59.52	21.84	6.52	0.93	4.93	0.67	1.07	1.46	1.07	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	72.25	42.20	8.39	4.63	4.63	2.25	3.01	2.88	1.13	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	63.42	29.68	10.65	0.76	3.04	0.76	2.03	2.28	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	137.96	58.20	11.46	4.82	7.09	2.41	2.11	2.86	2.11	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	132.03	40.51	15.75	7.50	6.00	1.50	1.50	1.50	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	95.62	209.34	32.31	1.29	0.00	3.88	2.58	2.58	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	127.89	40.46	10.23	4.19	1.40	1.86	0.93	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	109.05	52.51	14.14	7.57	6.56	4.54	2.02	5.55	2.02	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	107.49	42.94	6.58	6.58	6.27	2.82	2.51	3.13	0.63	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	58.11	18.58	5.90	4.72	2.06	6.19	1.47	2.06	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	50.90	29.24	5.33	2.58	1.58	1.58	0.50	0.67	0.42	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	71.48	64.94	6.07	2.80	8.41	3.74	1.40	1.40	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	141.47	38.71	8.92	4.17	3.02	1.73	0.29	4.61	0.29	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	131.81	85.92	12.75	7.65	4.08	1.78	2.04	2.04	1.27	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	97.59	78.79	13.91	2.26	6.21	1.32	0.94	3.20	1.50	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	52.26	45.14	7.27	2.79	1.96	1.82	0.56	2.10	0.42	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	62.25	46.59	7.04	1.01	2.68	0.92	0.42	2.68	0.50	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	55.71	40.95	1.90	0.48	0.95	2.86	1.43	2.38	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	126.98	38.66	9.54	3.18	1.47	1.71	1.22	4.89	0.49	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	48.17	43.31	8.62	2.87	9.28	1.55	2.21	3.09	2.65	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	68.46	32.77	10.53	5.27	4.68	0.59	1.17	1.46	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	77.55	17.49	3.69	0.58	2.33	0.58	1.17	1.94	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	91.50	11.37	3.97	1.06	1.06	1.59	2.12	1.06	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	52.07	11.16	1.49	1.12	2.23	1.86	4.84	0.74	2.60	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	82.29	15.45	3.59	3.23	3.95	1.08	2.87	2.52	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	71.26	16.47	2.56	0.57	1.70	0.57	1.14	1.70	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	48.05	17.33	2.36	7.09	0.39	0.79	0.00	1.58	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	77.20	15.74	3.81	1.78	3.56	1.52	2.54	0.76	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	72.28	23.16	5.59	1.60	5.99	1.60	2.40	0.80	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	101.58	20.48	4.18	1.67	5.43	0.42	3.34	1.67	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	100.84	26.58	7.33	2.29	5.96	1.83	2.75	0.92	0.46	0.00
Synoviocyte, donor1	11291-117A4	68.34	16.33	5.05	1.51	0.50	1.01	0.84	2.52	0.00	0.17
Synoviocyte, donor2	11368-117I9	62.52	32.85	7.38	6.87	2.18	4.02	2.85	2.18	0.34	0.84
Synoviocyte, donor3	11440-118H9	35.08	17.65	4.92	2.01	1.79	1.12	1.12	1.12	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	121.85	77.18	14.65	4.29	7.50	5.72	1.07	1.07	1.43	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	148.65	29.73	0.00	0.00	7.93	3.96	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	153.28	107.67	11.11	4.40	6.95	3.24	2.32	1.62	2.08	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	116.56	26.81	4.59	3.80	2.37	0.72	0.50	1.29	0.57	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	121.38	49.87	6.57	6.19	4.25	2.32	0.77	2.32	1.55	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	94.49	29.78	4.58	2.29	4.01	0.00	0.57	1.15	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	192.66	32.85	9.96	8.49	4.31	5.04	3.08	2.71	1.85	1.35
Urethra, donor2	10319-105A4	25.18	178.04	5.40	3.60	12.59	3.60	5.40	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	102.01	37.46	7.17	4.52	0.53	0.80	1.06	4.78	0.27	0.53
Urothelial Cells, donor2	11600-120H7	83.32	34.85	3.20	8.41	2.00	1.60	1.20	1.60	0.00	0.00
Urothelial Cells, donor3	11681-122H7	97.87	55.93	6.19	4.13	1.83	2.75	1.60	1.38	0.00	0.69
Urothelial cells, donor0	11216-116B1	93.17	52.16	4.90	4.24	0.89	1.11	0.45	1.78	0.45	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	97.88	72.96	9.79	0.89	25.80	0.00	5.34	0.89	16.91	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	144.39	57.18	8.58	1.43	15.73	0.00	5.72	0.00	17.16	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	88.99	120.48	2.05	1.37	22.59	0.00	7.53	0.68	12.32	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	88.84	110.53	6.89	1.72	26.51	0.34	4.82	1.38	13.43	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	108.07	87.15	2.32	2.91	24.98	0.58	8.13	0.00	17.43	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	87.46	59.35	11.45	1.04	28.11	1.04	1.04	0.00	11.45	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	105.55	68.83	8.26	3.67	19.27	0.00	3.67	0.92	7.34	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	83.07	137.85	2.74	0.91	35.60	0.00	1.83	0.91	7.30	0.91
Wilms' tumor cell line:G-401	10809-111A8	71.92	74.51	9.62	2.10	3.70	0.49	0.62	1.60	0.25	0.49
Wilms' tumor cell line:HFWT	10597-108E3	187.45	80.96	9.68	3.52	2.64	1.76	0.88	4.40	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	65.92	95.25	11.73	12.57	2.23	0.84	1.12	0.56	0.00	0.28
achilles tendon, donor2	10292-104G4	37.20	66.13	2.07	2.07	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	68.84	128.50	14.79	3.06	1.27	0.51	1.78	0.76	0.76	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	117.48	86.14	11.14	10.68	4.18	1.86	2.32	0.00	3.71	2.55
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	112.18	160.61	11.51	12.70	7.72	1.31	2.14	1.19	2.73	2.97
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	92.52	154.83	15.78	20.68	4.90	0.00	1.63	1.90	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	38.79	58.75	2.25	13.77	2.25	3.37	3.65	0.00	4.50	4.22
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	110.82	34.68	5.92	6.98	1.69	1.27	1.69	0.21	0.85	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	49.00	43.83	2.45	0.00	0.54	0.54	1.09	0.27	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	90.33	45.39	3.53	20.27	1.76	2.64	0.00	0.00	0.00	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	69.83	69.42	5.31	0.41	0.41	0.82	2.04	0.82	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	120.37	252.39	19.03	9.71	4.27	1.55	1.94	1.94	1.94	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	33.67	15.64	1.10	3.86	0.37	0.92	0.37	0.18	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	70.21	31.20	3.90	0.00	0.00	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	62.28	101.32	3.02	1.16	3.49	0.46	2.09	2.32	0.93	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	166.21	31.84	6.21	3.37	1.55	1.55	2.33	0.52	0.00	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	76.86	21.33	2.92	1.17	0.29	0.00	0.29	0.29	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	49.26	27.42	5.58	0.00	0.93	0.46	1.39	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	138.59	34.13	6.17	6.17	0.00	2.06	2.06	0.41	0.00	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	37.75	23.02	5.53	0.31	0.00	1.23	0.00	1.84	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	58.46	18.35	2.99	0.85	0.00	0.85	0.00	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	57.63	11.53	5.76	0.91	0.00	0.91	0.30	2.12	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	70.77	14.68	4.33	0.48	0.24	1.20	0.00	0.48	0.00	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	24.72	23.16	2.00	1.34	0.00	0.22	0.45	0.45	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	161.44	30.35	1.00	3.34	2.33	6.00	0.33	1.00	0.67	2.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	68.75	1.86	0.00	1.86	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	25.99	42.94	1.13	3.77	1.88	0.75	1.13	0.00	0.38	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.32	23.55	1.31	0.44	0.00	0.00	0.00	0.44	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	41.24	172.45	1.87	7.50	3.75	0.00	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	117.99	26.14	3.53	0.71	0.24	2.12	0.24	0.47	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	152.95	27.30	7.60	7.60	1.86	3.57	3.26	0.93	0.47	0.62
adipose, donor1	10184-103D4	40.46	22.28	5.86	0.00	0.00	0.00	1.76	0.00	0.00	0.00
adipose, donor2	10185-103D5	61.64	85.16	14.60	0.81	0.00	0.41	1.62	1.22	0.00	0.41
adipose, donor3	10186-103D6	57.73	54.19	8.71	0.54	0.00	0.82	1.09	0.82	0.00	0.82
adipose, donor4	10187-103D7	29.47	56.34	5.20	0.00	0.87	0.00	1.73	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	76.54	100.37	21.46	1.10	5.05	1.26	0.95	1.58	0.47	1.58
adrenal gland, adult, pool1	10081-102A9	167.33	112.77	10.91	0.00	10.91	47.29	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	144.61	33.35	5.87	6.67	0.53	2.80	1.07	1.07	0.00	3.74
alveolar cell carcinoma cell line:SW 1573	10708-109H6	154.35	31.44	8.22	8.22	1.79	0.36	1.07	0.71	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	133.31	16.00	9.51	5.56	0.23	0.23	2.32	0.23	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	94.67	29.41	13.19	1.35	0.34	0.34	2.03	2.37	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	84.26	10.02	5.89	2.95	0.00	0.00	0.88	0.59	0.00	0.00
amygdala - adult, donor10196	10167-103B5	175.50	69.96	11.86	16.60	0.00	5.93	1.19	2.37	0.00	1.19
amygdala, adult, donor10252	10151-102I7	234.20	95.71	22.10	13.18	2.64	7.91	2.64	3.24	1.22	2.03
amygdala, newborn, donor10223	10360-105E9	135.24	41.96	5.49	11.30	1.29	2.26	2.58	1.29	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	96.13	36.93	4.20	2.42	2.29	1.27	1.40	3.69	1.02	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	123.33	86.93	17.43	13.46	0.44	1.32	0.88	0.88	0.00	4.63
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	171.03	126.93	15.37	1.67	5.34	3.01	2.67	1.34	2.34	0.33
aorta, adult, pool1	10052-101G7	146.71	81.20	15.89	5.49	7.06	3.33	1.57	2.35	1.18	0.98
appendix, adult	10189-103D9	138.17	69.47	9.31	3.49	11.64	2.72	3.10	2.33	2.33	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	74.63	51.93	5.85	0.69	2.41	0.69	1.03	0.69	0.69	1.03
artery, adult	10190-103E1	464.67	35.33	13.59	148.10	5.43	40.76	5.43	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	54.04	29.41	7.53	2.90	0.00	1.01	0.43	1.59	0.14	1.01
b cell line:RPMI1788	10427-106D4	61.86	43.27	5.20	3.72	1.34	0.30	0.74	1.04	0.45	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	165.36	52.16	13.04	5.55	4.44	3.05	2.22	3.33	1.11	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	61.33	19.95	2.98	0.60	0.10	0.30	0.30	1.79	0.20	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	65.95	3.68	2.34	0.50	0.17	1.84	0.00	0.17	0.00	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.77	12.30	1.68	3.36	0.00	0.56	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	301.26	40.41	15.10	6.74	9.23	2.61	3.59	4.78	2.61	1.09
blood, adult, pool1	10053-101G8	95.23	431.85	8.86	4.43	79.73	0.00	13.29	0.00	22.15	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	132.73	29.12	21.41	1.71	0.00	0.00	0.00	0.86	0.86	0.86
bone marrow, adult	10192-103E3	37.12	22.94	3.37	2.02	1.35	3.37	0.67	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	229.62	110.71	22.55	8.20	4.10	4.10	4.10	3.08	2.05	1.03
brain, adult, pool1	10012-101C3	302.11	41.98	12.58	15.37	1.34	4.23	2.90	2.67	2.00	1.00
brain, fetal, pool1	10085-102B4	256.45	395.37	32.06	16.03	5.34	5.34	10.69	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	89.53	16.52	4.96	3.30	0.00	0.00	0.33	0.33	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	212.82	22.34	7.11	5.49	1.00	3.50	0.50	1.00	0.12	0.75
breast, adult, donor1	10080-102A8	150.89	148.37	21.47	0.00	15.15	5.05	3.16	1.89	3.79	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	78.13	88.80	11.43	3.30	3.18	2.92	2.16	0.76	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	53.80	38.03	5.57	4.02	1.55	0.93	0.62	1.55	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	64.00	15.42	4.60	24.17	1.15	0.69	2.30	1.38	0.46	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	27.84	27.84	1.69	0.48	0.48	0.00	0.48	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	139.17	56.89	11.28	7.99	0.47	2.35	0.00	2.35	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	214.28	160.02	14.55	15.20	1.97	3.72	1.20	4.05	1.31	1.53
carcinoid cell line:SK-PN-DW	10719-109I8	71.94	72.89	10.77	3.80	1.58	1.27	0.95	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	111.00	59.89	5.32	1.06	1.33	0.53	2.13	1.33	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	156.58	63.32	10.36	42.60	1.15	4.61	1.15	0.00	2.30	2.30
caudate nucleus, adult, donor10252	10164-103B2	180.71	59.57	16.40	30.45	1.51	5.35	1.84	2.34	1.34	2.01
caudate nucleus, adult, donor10258	10379-105H1	243.00	50.43	10.70	53.49	1.53	7.64	1.53	0.00	0.00	6.11
caudate nucleus, newborn, donor10223	10354-105E3	122.69	34.79	4.39	19.78	0.73	2.93	2.20	0.37	0.37	1.83
cerebellum - adult, donor10196	10173-103C2	422.42	55.35	2.91	26.22	0.00	8.74	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	529.29	57.43	12.38	27.97	4.06	13.24	5.76	2.78	1.28	1.71
cerebellum, adult, pool1	10083-102B2	495.69	103.48	21.04	20.35	2.41	14.83	4.48	2.41	1.38	3.10
cerebellum, newborn, donor10223	10357-105E6	280.64	39.85	9.13	38.19	0.00	6.64	9.13	0.00	2.49	2.49
cerebral meninges, adult	10188-103D8	324.25	53.20	16.64	10.09	0.76	6.05	4.54	3.03	1.01	1.26
cerebrospinal fluid, donor2	10294-104G6	49.70	26.31	3.65	19.73	0.73	5.85	0.73	2.92	0.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	140.62	19.55	3.74	18.40	0.00	3.16	0.58	0.43	0.00	0.72
cervical cancer cell line:ME-180	10553-107I4	196.71	35.79	5.14	24.86	0.50	2.82	1.33	0.66	0.17	2.32
cervix, adult, pool1	10013-101C4	274.34	56.48	14.49	5.25	18.37	4.83	6.61	4.51	8.92	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	141.15	14.77	5.16	3.48	0.84	1.81	0.84	2.51	0.28	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	105.81	13.06	0.00	0.00	0.00	0.00	6.53	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	108.12	20.51	4.97	5.47	1.24	0.12	1.37	1.12	0.87	0.50
choriocarcinoma cell line:SCH	10785-110H2	48.67	17.13	3.70	0.74	2.34	0.00	0.00	0.25	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	65.70	7.35	3.56	0.47	1.42	0.24	0.00	0.95	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	193.18	31.91	16.53	6.27	1.99	1.42	2.85	0.57	1.42	1.71
chorionic membrane cells, donor2	12239-129G7	167.34	61.25	17.10	6.16	5.37	1.89	5.67	3.08	2.59	1.29
chorionic membrane cells, donor3	12240-129G8	168.69	24.73	13.19	7.14	3.30	1.10	2.75	0.55	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	52.51	105.02	8.08	30.29	1.01	2.02	9.09	0.00	1.01	7.07
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	33.81	55.32	4.61	0.19	1.15	1.15	0.38	0.38	0.00	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	30.41	63.14	2.96	0.00	5.70	1.27	0.00	0.42	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	118.90	23.88	3.85	1.03	2.82	1.03	2.05	0.77	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	106.91	28.06	6.05	0.73	4.84	0.00	0.97	1.94	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	104.45	26.47	2.04	1.02	4.28	0.20	2.65	1.22	0.81	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	160.18	24.15	7.36	2.06	1.77	0.00	0.88	2.94	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	78.97	45.87	1.30	3.65	2.61	4.69	0.52	0.26	0.78	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	50.97	27.43	4.34	1.37	1.37	0.46	1.37	0.69	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	65.93	8.68	5.55	0.52	0.00	0.52	0.35	0.00	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	40.45	24.34	7.14	0.37	0.18	0.00	0.73	1.65	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	64.99	21.66	5.32	0.76	0.38	0.00	1.14	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	248.72	174.93	17.85	11.90	15.47	20.23	3.57	1.19	1.19	2.38
colon, adult, pool1	10014-101C5	287.65	35.37	16.33	7.29	4.58	7.52	6.11	3.17	1.18	2.23
colon, fetal, donor1	10070-101I7	105.68	129.78	14.21	4.33	20.39	8.03	1.24	2.47	3.09	5.56
common myeloid progenitor CMP, donor1	12130-128D6	165.01	22.92	22.92	0.00	0.00	0.00	0.00	22.92	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	50.07	0.00	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	57.37	12.32	4.25	4.67	0.00	0.42	0.00	0.00	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	53.73	22.79	4.98	11.92	0.15	0.60	1.36	0.15	0.00	2.11
cord blood derived cell line:COBL-a untreated	10449-106F8	63.17	30.04	4.79	12.69	0.42	0.99	0.71	0.14	0.00	2.12
corpus callosum, adult, pool1	10042-101F6	158.21	30.07	9.51	4.98	2.65	4.09	1.44	3.76	3.32	0.55
cruciate ligament, donor2	10295-104G7	44.58	52.68	2.43	8.10	2.43	3.24	0.81	0.00	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	154.89	112.36	12.84	51.36	3.21	30.50	1.61	0.80	0.00	3.21
diencephalon, adult	10193-103E4	157.91	48.24	13.44	18.96	1.44	4.80	2.16	2.16	1.44	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	105.85	92.30	7.58	2.53	2.53	1.61	4.59	0.69	1.15	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	78.98	8.46	2.56	0.51	0.51	0.77	0.26	0.77	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	79.20	23.83	5.54	2.65	2.41	0.96	0.24	0.96	0.96	0.48
ductus deferens, adult	10196-103E7	241.20	43.85	9.97	6.48	5.98	10.96	2.99	5.98	1.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	145.46	203.07	11.52	8.64	10.08	11.52	1.44	1.44	0.00	8.64
duodenum, fetal, donor1, tech_rep2	10071-101I8	156.69	50.76	6.62	6.62	5.89	10.30	4.41	1.47	0.74	0.74
dura mater, adult, donor1	10041-101F5	147.34	39.97	6.77	3.63	2.06	2.81	0.58	2.89	0.91	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	45.97	2.89	1.11	0.67	0.00	0.00	0.44	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	67.63	7.31	2.44	1.72	0.00	0.29	1.00	0.14	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	78.31	48.71	3.70	0.62	7.40	0.62	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	120.18	29.67	4.84	0.61	6.96	0.61	1.21	0.61	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	83.05	35.20	4.63	1.23	4.94	0.93	0.00	0.31	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	98.51	56.48	1.31	0.00	2.63	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	30.84	18.44	5.03	0.67	0.00	0.34	0.00	1.01	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	253.37	58.00	18.12	2.72	7.97	1.45	3.26	5.07	1.45	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	73.49	17.85	5.31	1.45	0.00	0.48	1.61	0.64	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	73.81	16.56	3.56	4.67	1.11	0.33	0.33	0.56	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	62.25	22.55	4.73	8.03	0.00	0.44	0.22	0.77	0.00	0.99
epididymis, adult	10197-103E8	149.87	33.07	8.58	3.98	5.44	3.56	3.14	2.93	2.30	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	129.69	28.21	7.98	0.89	4.97	0.00	0.89	2.13	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	121.12	18.88	5.11	0.39	1.97	1.18	0.00	0.79	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	100.91	55.17	4.72	36.43	0.13	3.28	1.97	0.26	0.13	3.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	83.16	43.01	3.54	27.75	0.00	3.44	0.69	0.49	0.00	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	107.55	69.35	6.83	43.58	0.90	6.05	1.34	0.67	0.00	3.14
esophagus, adult, pool1	10015-101C6	270.54	33.45	8.60	15.29	2.44	6.37	4.99	1.81	0.74	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	158.17	26.80	7.01	0.50	0.88	0.75	0.75	2.38	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	99.00	60.36	12.07	0.00	4.83	16.90	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	37.88	2.10	4.21	2.10	8.42	0.00	0.00	0.00	4.21
eye - muscle medial, donor2	10299-104H2	61.02	71.43	11.91	0.00	4.46	19.35	1.49	1.49	1.49	1.49
eye - muscle superior, donor2	10297-104G9	29.81	67.64	4.59	8.03	3.44	6.88	1.15	3.44	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	46.64	56.84	8.74	0.00	11.66	0.00	0.00	4.37	2.91	0.00
eye, fetal, donor1	10054-101G9	160.42	123.56	14.24	4.07	6.61	6.61	3.31	2.54	1.78	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	50.14	78.47	7.82	1.28	2.44	0.13	0.38	1.92	0.38	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	68.61	63.87	6.89	4.99	2.14	0.71	0.47	2.85	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	345.93	52.35	17.36	17.64	0.94	4.88	0.84	3.00	1.22	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	126.10	33.93	3.60	2.40	0.90	0.60	0.60	1.80	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	76.99	13.17	5.21	0.73	0.18	0.46	0.09	2.38	0.00	0.00
gall bladder, adult	10198-103E9	236.85	53.84	7.97	7.24	3.14	14.00	6.04	2.90	1.69	1.69
gamma delta positive T cells, donor1	11937-126A2	317.82	278.09	20.94	18.79	71.94	6.98	7.52	1.61	24.16	23.08
gamma delta positive T cells, donor2	11938-126A3	306.64	280.87	22.78	10.83	60.88	4.86	10.08	1.49	24.65	9.71
gastric adenocarcinoma cell line:MKN1	10614-108G2	103.92	24.92	3.38	0.00	0.21	0.63	1.06	0.00	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	162.47	24.76	4.84	2.51	0.00	1.35	1.35	0.58	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	111.82	29.84	11.31	5.74	1.15	0.49	0.33	2.30	0.49	0.66
gastric cancer cell line:GSS	10560-108A2	67.73	24.71	2.75	2.75	0.92	0.00	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	150.10	101.21	5.71	1.83	6.63	0.46	5.03	1.14	6.40	1.60
giant cell carcinoma cell line:LU65	10487-107B1	70.91	5.28	1.38	3.56	0.00	1.03	0.23	0.00	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	78.38	24.21	3.50	4.76	2.52	1.40	1.40	2.66	1.12	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	64.35	26.19	4.49	3.74	2.49	1.00	0.25	0.75	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	185.14	39.48	14.04	3.27	2.43	0.74	0.74	4.01	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	190.43	81.03	22.61	4.21	3.09	0.84	0.98	5.48	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	36.31	30.79	9.82	1.32	0.55	0.55	0.55	2.10	0.11	0.11
glioma cell line:GI-1	10413-106B8	65.90	16.40	4.10	0.88	1.17	0.88	1.17	1.46	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	137.04	68.52	8.02	15.31	2.19	4.37	1.46	2.92	1.46	1.46
globus pallidus, adult, donor10252	10161-103A8	200.89	71.76	10.74	14.65	4.39	8.54	1.46	4.64	4.39	2.69
globus pallidus, adult, donor10258	10367-105F7	197.17	50.66	13.69	17.80	5.48	6.85	4.11	1.37	4.11	5.48
globus pallidus, newborn, donor10223	10364-105F4	117.24	30.38	3.20	20.25	0.53	3.73	1.60	1.07	0.00	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	95.44	56.28	12.24	0.00	2.45	0.00	0.00	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	32.79	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	36.59	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	142.40	44.16	9.28	0.32	2.88	2.24	2.24	1.28	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	49.58	44.53	4.59	2.30	4.59	0.00	0.46	2.75	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	48.47	23.78	3.20	4.57	3.20	0.00	0.91	0.91	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	55.39	34.78	5.15	4.51	3.22	0.64	1.29	1.29	0.00	0.64
hIPS, biol_rep1	14380-156B6	70.43	17.25	1.44	1.44	1.44	1.44	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	45.95	40.47	4.80	9.60	5.49	0.69	2.06	2.74	0.69	0.00
hIPS, biol_rep3	14382-156B8	192.00	37.52	4.41	19.86	2.21	6.62	1.10	2.21	1.10	5.52
hairy cell leukemia cell line:Mo	10712-109I1	62.35	46.55	3.16	9.19	0.57	0.29	0.29	0.29	0.00	0.86
heart - mitral valve, adult	10205-103F7	217.95	71.15	10.16	8.67	4.78	7.18	2.69	5.98	1.20	0.90
heart - pulmonic valve, adult	10206-103F8	264.87	45.24	12.03	17.78	2.35	12.29	3.66	2.88	1.31	1.57
heart - tricuspid valve, adult	10207-103F9	144.05	73.27	8.33	4.16	1.67	2.50	0.83	8.33	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	185.28	77.95	13.88	9.18	2.04	7.55	2.86	0.82	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	383.25	122.21	22.14	21.29	4.26	14.90	7.24	2.55	1.28	2.55
heart, adult, pool1	10016-101C7	584.83	64.62	24.84	59.33	2.07	8.28	2.53	4.83	0.92	1.38
heart, fetal, pool1	10046-101G1	263.37	71.77	13.96	14.68	1.13	13.04	1.85	4.21	0.92	2.26
hepatic mesenchymal tumor cell line:LI90	10778-110G4	109.83	87.31	11.11	0.31	5.24	1.54	0.31	4.63	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	5.95	2.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	53.04	27.96	2.65	1.77	0.00	1.10	0.44	0.22	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	47.94	26.70	3.03	1.46	0.00	1.46	0.61	0.12	0.00	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	50.73	25.57	2.73	1.52	0.00	1.82	0.81	0.61	0.00	0.40
hepatoma cell line:Li-7	10484-107A7	85.08	18.68	3.34	4.11	1.22	7.45	1.11	0.78	0.78	1.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	62.81	37.39	6.33	7.84	0.10	0.40	0.30	0.40	0.00	1.21
hippocampus - adult, donor10196	10169-103B7	193.05	91.79	12.30	18.93	0.95	3.79	0.95	0.95	0.00	2.84
hippocampus, adult, donor10252	10153-102I9	241.25	83.89	22.25	15.10	2.25	5.71	1.84	3.88	2.04	2.45
hippocampus, adult, donor10258	10374-105G5	264.41	21.41	5.98	12.45	1.49	4.98	0.00	2.49	0.00	2.49
hippocampus, newborn, donor10223	10363-105F3	139.23	43.35	7.40	25.73	1.06	5.64	2.11	2.11	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	47.00	23.80	4.88	5.49	0.00	0.00	2.44	0.00	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.95	50.27	5.89	3.93	1.37	0.20	1.18	1.37	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	43.16	29.71	4.32	6.35	0.51	0.51	1.27	1.52	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.01	20.30	3.95	0.56	0.00	0.00	1.69	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.02	43.38	9.30	0.00	0.00	0.00	3.61	0.26	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.90	17.46	1.52	0.76	0.00	0.00	1.90	0.00	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	58.68	23.65	6.71	1.17	0.29	0.00	4.09	1.46	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.47	45.24	10.13	0.43	0.65	0.00	5.39	1.08	0.43	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.88	31.70	7.09	2.92	0.42	0.42	2.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	63.22	21.78	5.45	2.37	0.00	0.95	2.13	0.71	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	53.68	48.05	8.68	0.80	0.32	0.48	2.73	0.64	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	64.64	27.61	9.43	2.69	0.00	0.00	1.35	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.74	75.58	7.20	7.98	2.82	0.94	3.29	1.10	0.16	2.66
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.85	64.36	9.83	7.37	0.98	1.47	6.39	2.46	0.00	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.89	15.71	0.87	8.73	0.00	0.87	3.49	0.87	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	39.71	35.32	7.64	0.19	0.00	0.00	1.72	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	39.25	28.34	6.11	0.00	0.00	0.00	1.31	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	41.98	15.99	2.00	1.00	0.00	0.50	1.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	38.62	49.74	6.59	0.94	0.38	0.75	3.39	1.70	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	37.74	46.84	4.09	0.45	0.45	0.00	1.82	0.91	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.55	23.18	3.45	1.57	0.31	0.00	3.45	1.88	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	40.01	33.97	4.41	1.80	0.16	0.65	2.29	0.16	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	41.80	26.71	6.39	0.58	0.00	0.87	1.45	0.00	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	57.69	23.02	5.38	2.09	0.00	0.60	2.09	0.00	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	32.15	57.09	4.80	3.69	0.55	0.18	2.96	1.11	0.37	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	36.52	60.77	5.42	2.28	0.29	0.29	4.28	1.71	0.00	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	41.24	30.22	3.27	3.67	0.00	0.00	3.67	0.41	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	24.65	24.29	6.34	1.06	0.00	0.35	1.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.92	23.44	7.29	0.63	0.00	0.00	2.22	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	33.59	16.04	2.72	0.30	0.00	0.00	2.12	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	35.16	40.34	3.62	1.03	0.52	0.52	3.62	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.19	41.18	6.64	0.66	0.00	0.66	3.32	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	46.95	16.67	4.10	0.00	0.26	0.00	3.08	0.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	30.17	28.89	5.62	0.51	0.00	0.26	2.56	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	45.43	28.02	6.82	0.00	0.00	0.76	3.03	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	41.00	20.50	4.70	1.34	0.00	0.00	3.02	0.67	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	38.16	53.61	8.69	5.07	1.21	0.48	1.45	0.72	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	48.58	26.29	2.67	3.12	0.00	0.00	0.89	1.34	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	43.90	40.49	4.88	3.41	0.49	1.46	3.90	0.49	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	32.09	27.20	3.67	0.31	0.00	0.31	2.75	0.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	19.52	3.25	0.00	0.00	0.00	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.07	12.91	1.65	0.33	0.00	0.00	2.32	0.00	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	48.16	31.74	5.47	0.55	0.55	0.55	4.38	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	44.87	23.52	5.07	2.17	0.36	0.36	2.90	1.81	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	40.21	16.37	3.91	0.36	0.00	0.00	2.85	1.42	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	38.19	23.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	51.46	26.54	7.04	0.41	0.14	0.14	2.17	0.68	0.00	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	41.76	20.20	3.50	0.54	0.00	0.27	0.81	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	138.75	18.16	8.96	1.70	2.91	1.70	0.24	0.73	0.24	1.94
immature langerhans cells, donor2	11905-125F6	129.91	41.19	5.54	2.38	6.34	0.00	3.17	1.58	0.00	2.38
insula, adult, pool1	10039-101F3	399.07	62.84	24.42	21.29	1.04	5.58	1.32	3.22	2.18	1.42
keratoacanthoma cell line:HKA-1	10791-110H8	56.90	166.15	11.71	7.15	5.53	0.98	0.98	0.65	0.33	1.95
kidney, adult, pool1	10017-101C8	176.52	30.74	6.61	7.81	2.90	9.81	2.50	2.30	1.50	2.40
kidney, fetal, pool1	10045-101F9	136.38	41.17	7.00	4.17	1.63	4.46	0.92	2.41	0.78	1.70
large cell lung carcinoma cell line:IA-LM	10509-107D5	67.60	58.09	9.09	0.14	2.98	0.14	0.71	8.10	1.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	70.50	21.70	3.32	0.28	0.00	0.41	1.80	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.11	22.75	2.02	4.22	0.18	0.55	0.37	2.39	0.18	0.00
left atrium, adult, donor1	10079-102A7	274.06	162.37	25.06	17.98	3.81	13.62	3.81	2.72	2.72	2.72
left ventricle, adult, donor1	10078-102A6	220.47	189.62	15.68	27.81	1.01	20.73	2.53	1.52	0.00	3.03
leiomyoblastoma cell line:G-402	10721-110A1	106.71	100.69	14.77	14.50	13.95	1.92	0.55	1.92	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	63.59	26.94	7.54	2.51	6.47	2.16	7.18	2.87	1.44	0.36
leiomyoma cell line:15242A	10570-108B3	69.02	20.65	3.26	2.17	7.61	0.54	4.35	1.63	0.54	0.00
leiomyoma cell line:15425	10571-108B4	78.67	28.90	7.04	5.34	9.23	2.67	4.13	2.19	2.43	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	120.64	31.75	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	135.92	44.96	11.50	4.18	1.05	2.09	1.05	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	62.10	56.79	4.49	0.00	8.15	0.24	0.35	1.65	0.59	0.00
liposarcoma cell line:KMLS-1	10782-110G8	57.17	23.43	8.59	1.72	1.25	0.78	0.94	1.09	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	41.06	150.11	12.79	1.95	3.53	1.46	0.61	0.85	0.24	0.49
liver, adult, pool1	10018-101C9	116.68	12.80	7.45	3.57	0.97	8.75	0.65	0.00	0.00	1.62
liver, fetal, pool1	10086-102B5	52.68	54.56	6.58	1.88	0.94	2.82	0.00	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	176.01	71.31	9.62	8.75	4.52	10.50	1.02	2.33	0.87	3.50
locus coeruleus, adult, donor10252	10165-103B3	181.23	57.76	11.44	7.57	4.24	8.86	1.85	3.69	2.03	2.95
locus coeruleus, adult, donor10258	10375-105G6	147.84	71.95	11.00	5.92	4.23	14.39	3.95	2.26	0.85	6.49
locus coeruleus, newborn, donor10223	10362-105F2	108.52	23.13	2.52	7.57	1.26	4.21	2.10	1.26	0.00	2.10
lung adenocarcinoma cell line:A549	10499-107C4	94.80	13.70	4.57	7.20	2.77	0.55	0.42	0.97	1.25	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	74.46	24.82	8.96	0.69	0.00	0.00	0.00	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	66.83	33.09	7.12	2.11	0.13	1.45	0.26	3.30	0.00	0.66
lung, adult, pool1	10019-101D1	187.70	45.83	10.87	5.32	5.43	2.84	3.31	3.07	2.01	0.12
lung, fetal, donor1	10068-101I5	235.46	33.96	8.56	3.42	8.85	2.85	4.28	2.57	4.00	1.14
lung, right lower lobe, adult, donor1	10075-102A3	217.65	137.46	18.33	5.50	16.95	7.33	7.79	4.58	4.58	3.67
lymph node, adult, donor1	10077-102A5	97.51	190.77	9.47	1.42	33.14	0.95	1.89	0.95	1.89	0.00
lymphangiectasia cell line:DS-1	10727-110A7	34.63	38.14	5.48	0.88	0.44	0.22	0.22	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	70.63	41.96	7.55	1.21	3.62	0.45	1.06	0.30	0.45	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	42.47	10.19	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	307.24	14.65	15.54	15.10	0.00	3.55	0.44	1.33	0.00	2.22
mature adipocyte, donor2	12232-129F9	392.44	20.55	9.75	8.92	0.62	8.09	0.83	1.87	0.00	0.42
mature adipocyte, donor3	12233-129G1	311.97	15.17	12.56	10.43	0.24	5.45	1.90	1.42	0.00	0.47
mature adipocyte, donor4	12234-129G2	172.41	7.63	7.37	6.32	0.53	1.32	1.05	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	101.26	19.54	8.58	0.24	0.71	0.00	0.24	1.43	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	291.03	57.53	12.41	28.20	1.13	6.77	5.64	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	287.08	60.14	16.18	12.87	2.57	6.80	2.21	1.29	0.92	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	369.15	49.24	14.61	23.19	2.22	5.08	2.22	1.59	0.95	4.77
medial frontal gyrus, newborn, donor10223	10352-105E1	139.04	16.21	2.56	19.19	0.43	2.99	2.56	0.85	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	377.66	78.13	19.07	21.43	1.18	5.74	3.88	1.52	0.68	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	295.84	71.94	15.28	12.95	2.76	8.28	0.85	1.91	1.06	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	306.28	11.56	5.78	11.56	0.00	5.78	1.93	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	14.35	14.35	28.71	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	190.23	56.35	9.33	17.23	1.44	3.59	1.44	1.79	0.72	1.08
medulla oblongata - adult, donor10196	10174-103C3	99.94	42.83	4.54	9.09	5.84	8.44	0.65	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	171.83	45.20	6.04	11.15	4.33	8.51	1.39	2.94	0.62	1.86
medulla oblongata, adult, pool1	10038-101F2	187.25	30.45	9.71	9.80	2.37	5.63	0.82	5.14	1.55	2.20
medulla oblongata, newborn, donor10223	10361-105F1	93.39	26.04	2.78	11.80	1.74	5.90	1.04	1.39	0.00	1.74
medulloblastoma cell line:D283 Med	10838-111E1	222.74	28.12	5.98	13.28	4.43	7.75	3.32	2.66	1.11	2.66
medulloblastoma cell line:ONS-76	10759-110E3	92.93	91.95	6.48	0.49	6.24	1.22	0.49	3.42	1.96	0.12
melanoma cell line:COLO 679	10514-107E1	84.52	23.72	6.18	5.46	1.01	1.29	0.29	2.44	0.00	0.72
melanoma cell line:G-361	10465-106H6	72.48	19.82	4.61	0.27	0.00	0.81	1.36	2.17	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	68.20	24.96	2.35	1.45	1.09	1.27	1.99	2.17	0.54	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	192.09	113.67	16.74	6.17	5.29	4.41	3.52	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	168.24	212.30	14.52	10.89	25.66	4.67	10.63	4.15	11.92	2.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	45.11	19.49	6.90	1.23	2.30	0.61	0.77	0.46	0.46	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	46.17	17.45	7.27	1.45	1.45	0.36	0.55	0.91	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	55.08	9.11	3.73	1.66	0.41	0.41	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	52.26	10.96	7.59	1.69	0.14	1.26	0.56	0.84	0.28	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	48.72	15.79	6.35	1.93	0.58	0.96	1.16	0.39	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	61.77	4.16	3.47	4.16	2.08	4.16	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	71.91	14.93	6.52	1.37	0.51	2.40	0.86	2.40	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	56.24	12.65	5.52	3.57	1.61	2.30	1.27	1.84	0.46	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	56.77	24.94	7.03	3.05	1.33	0.93	0.80	1.19	0.80	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	66.71	33.76	10.40	4.59	1.08	1.35	1.35	0.81	0.68	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	68.14	37.27	8.39	4.13	3.13	2.28	1.14	2.28	1.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	61.92	12.19	3.62	0.33	0.99	2.63	0.99	1.32	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	83.71	26.71	10.24	2.08	1.25	0.69	0.97	1.52	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	74.01	23.74	5.93	2.09	1.75	0.70	0.70	1.75	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	79.01	25.11	8.98	6.12	0.82	1.84	1.22	3.06	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	94.18	32.71	4.31	2.16	3.59	2.88	4.67	3.95	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	64.97	23.69	7.97	3.62	1.03	0.83	0.52	2.28	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	68.40	28.04	2.28	2.74	4.33	1.60	2.05	2.28	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	57.48	16.36	4.20	3.78	0.84	0.84	0.00	2.52	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	66.20	19.58	7.17	1.49	0.90	1.20	1.20	1.64	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	72.30	33.61	8.32	5.60	2.36	0.79	1.31	2.63	0.44	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	103.82	29.82	5.89	3.68	1.84	2.58	1.84	2.95	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	95.29	35.20	4.86	2.00	3.72	2.00	4.58	2.00	1.43	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	130.51	52.21	8.42	6.32	2.11	1.68	3.37	1.26	1.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	68.96	26.49	8.22	2.74	5.02	0.91	0.46	1.83	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	54.99	19.70	5.12	2.81	1.79	1.02	1.53	3.07	0.77	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	55.23	20.94	8.11	2.88	2.36	2.09	0.79	2.09	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	60.08	23.72	5.85	1.85	1.54	0.92	2.16	1.54	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	53.90	19.77	4.71	2.59	2.59	1.18	1.88	0.94	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	53.48	22.68	4.74	4.74	1.35	1.02	0.34	1.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	53.84	23.58	4.72	3.54	2.36	1.96	1.18	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	49.12	18.07	4.63	1.85	2.78	0.93	0.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.30	26.25	8.94	3.17	3.17	0.58	1.15	0.58	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	59.57	20.53	6.25	2.90	3.57	1.56	0.89	0.67	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	46.63	21.39	4.33	3.12	2.88	0.96	0.72	0.48	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	48.40	19.80	3.67	1.47	3.67	0.73	0.00	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	56.05	15.44	5.71	2.35	2.69	1.01	0.34	2.35	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	49.94	15.97	4.91	3.28	4.91	1.23	1.23	1.64	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	52.41	19.33	4.73	3.87	3.44	1.72	2.58	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	109.38	13.67	0.00	8.20	2.73	0.00	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	10.33	0.00	0.00	0.00	0.00	0.00	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	70.15	19.81	4.87	4.22	2.27	1.62	2.60	0.97	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	53.83	24.73	4.36	1.45	0.00	1.45	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	72.50	30.92	10.13	5.33	2.67	3.20	3.73	2.13	0.53	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	53.16	17.17	9.00	0.82	4.91	0.00	2.45	2.45	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	66.08	24.49	8.94	3.89	2.33	1.17	1.94	1.17	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	20.99	4.20	0.00	2.10	0.00	2.10	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	54.64	13.91	2.98	0.99	0.00	0.00	1.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	4.77	9.53	0.00	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	65.82	20.75	2.96	2.96	1.19	2.37	3.56	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	70.67	30.46	12.18	3.66	8.53	4.87	3.66	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	64.61	24.07	6.97	3.80	3.80	0.00	2.53	1.27	2.53	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	48.29	16.21	5.86	2.41	3.10	1.72	1.72	1.03	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	62.33	15.04	6.45	0.00	4.30	0.00	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	7.98	3.99	0.00	11.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	10.33	10.33	0.00	0.00	0.00	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	48.49	19.56	8.15	0.81	4.89	0.41	0.41	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	54.02	18.27	6.36	0.00	1.59	0.79	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	60.13	18.86	5.31	0.59	1.18	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	54.24	17.46	6.55	0.00	3.12	1.87	1.25	1.87	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	61.49	21.39	6.68	0.00	4.01	4.01	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	65.05	16.56	2.37	1.18	0.00	2.37	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	71.90	7.70	5.14	2.57	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	61.27	17.21	7.57	2.07	1.38	4.82	0.69	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	74.72	22.27	13.36	3.96	0.00	11.38	2.47	0.00	0.49	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	67.29	19.07	4.49	6.73	0.00	12.34	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	74.42	22.26	10.18	5.72	0.00	8.27	1.27	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	86.24	35.87	6.85	6.04	0.00	13.30	1.61	2.42	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	93.77	30.53	10.90	6.54	0.00	19.63	6.54	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	98.83	32.94	6.34	5.07	0.00	8.87	2.53	1.27	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	73.43	20.63	7.28	4.86	0.00	1.21	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	18.08	0.00	4.52	0.00	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	67.54	18.94	5.77	4.12	0.00	8.24	3.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	83.74	20.24	8.93	2.58	0.99	5.16	1.59	1.39	0.20	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	71.71	39.59	7.46	2.92	0.65	6.49	2.60	0.65	0.65	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	68.25	34.63	13.24	3.06	0.00	3.06	2.04	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	110.64	52.61	19.34	6.96	0.77	5.42	0.00	6.19	0.00	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	119.54	19.84	8.74	1.89	2.83	0.71	0.94	2.60	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	139.47	84.33	8.80	6.26	10.43	1.16	6.26	3.01	5.56	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	136.76	29.92	4.27	8.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	108.20	22.50	3.90	6.37	2.06	1.64	0.41	1.85	0.10	1.03
mesothelioma cell line:Mero-25	10850-111F4	43.80	42.44	1.59	5.45	2.50	0.68	0.91	0.45	1.36	1.59
mesothelioma cell line:Mero-41	10851-111F5	118.57	32.27	8.31	1.22	0.49	0.24	1.47	1.96	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	62.00	31.66	5.54	4.65	0.44	0.44	1.33	0.44	0.00	0.89
mesothelioma cell line:Mero-82	10853-111F7	100.39	47.57	6.31	1.84	0.53	1.31	1.84	1.84	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	74.05	29.11	4.09	4.09	0.51	1.02	1.02	1.02	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	36.40	65.47	6.07	8.09	8.34	2.78	5.31	0.51	2.27	0.51
mesothelioma cell line:Mero-95	10856-111G1	68.12	51.35	7.66	3.11	1.24	0.41	1.24	1.86	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	52.51	44.89	6.79	8.28	0.99	1.16	0.99	0.99	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	49.41	55.02	5.79	6.70	1.99	1.27	1.09	0.72	0.72	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	60.30	21.18	3.93	1.54	1.71	0.17	1.02	0.68	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	78.63	18.32	3.56	16.54	2.04	2.29	1.27	1.27	0.25	0.76
mesothelioma cell line:No36	10857-111G2	80.90	19.90	3.59	2.94	0.00	2.94	0.00	0.98	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	64.22	10.03	0.81	4.61	0.54	2.44	0.81	0.81	0.00	0.81
migratory langerhans cells, donor1	11901-125F2	101.53	8.06	4.22	2.88	0.96	0.58	2.11	0.38	0.19	0.58
migratory langerhans cells, donor2	11902-125F3	171.33	13.80	11.36	2.56	1.10	0.49	1.83	0.24	0.12	0.73
migratory langerhans cells, donor3	11903-125F4	214.12	22.97	16.69	1.44	4.13	1.08	2.15	1.26	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	145.94	33.30	5.22	0.33	0.00	2.29	3.26	0.98	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.06	39.84	3.81	8.48	0.00	3.81	1.27	0.64	0.00	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	197.65	111.26	16.36	1.15	6.22	0.69	0.23	2.53	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	75.93	147.10	12.18	26.45	4.19	3.81	0.95	0.57	0.95	10.66
myelodysplastic syndrome cell line:SKM-1	10772-110F7	140.63	19.96	3.14	9.98	0.00	1.85	0.74	0.92	0.00	1.48
myeloma cell line:PCM6	10474-106I6	310.14	64.44	9.09	4.94	0.20	1.19	1.78	1.38	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	91.31	30.94	12.68	0.00	0.51	1.01	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	81.01	7.65	6.86	1.18	2.35	1.96	0.00	0.59	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	103.40	30.08	3.34	4.01	0.45	0.67	0.33	0.33	0.11	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	109.87	20.15	2.21	3.68	0.37	0.51	0.44	0.44	0.22	0.22
nasal epithelial cells, donor2	12227-129F4	110.95	44.16	3.31	2.21	3.31	1.66	0.55	1.66	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	146.55	42.10	12.88	5.98	0.23	0.92	0.69	4.14	0.00	2.53
neuroblastoma cell line:NB-1	10539-107G8	130.40	64.73	10.66	6.55	0.75	4.30	0.75	5.80	0.19	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	130.96	69.59	12.65	4.01	0.00	0.84	2.74	1.90	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	136.78	56.46	5.96	2.98	0.93	0.56	0.75	1.68	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	131.90	104.62	7.35	0.47	4.03	0.00	1.90	1.66	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	107.70	181.50	14.73	7.44	6.34	1.27	2.53	1.90	0.63	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	78.89	77.48	9.26	3.02	2.82	0.81	0.40	1.01	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	102.36	218.70	22.25	4.45	6.99	0.00	0.64	2.54	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	77.72	77.99	9.32	2.66	8.25	3.73	0.53	3.46	0.80	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	56.66	82.36	3.89	4.06	0.68	0.51	0.51	1.01	0.34	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	148.09	91.26	13.61	16.01	3.20	0.80	3.20	4.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	92.33	92.01	19.56	0.64	5.13	3.21	2.89	2.24	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	153.19	41.52	6.83	4.99	2.89	5.78	4.47	1.31	1.58	1.58
nucleus accumbens, adult, pool1	10037-101F1	290.22	50.62	18.65	24.93	1.69	5.44	1.12	2.34	2.34	1.41
occipital cortex - adult, donor10196	10172-103C1	292.57	72.11	16.48	12.36	2.06	6.18	0.00	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	321.23	68.16	18.25	10.47	1.07	6.71	3.22	3.49	2.15	1.88
occipital cortex, newborn, donor10223	10355-105E4	184.88	37.49	7.64	21.11	0.36	1.82	4.00	1.82	0.36	1.82
occipital lobe, adult, donor1	10076-102A4	395.96	129.36	28.08	21.52	1.31	10.23	6.04	1.31	0.79	2.10
occipital lobe, fetal, donor1	10073-102A1	247.16	314.96	45.06	24.89	4.72	3.86	4.72	1.72	0.86	0.00
occipital pole, adult, pool1	10036-101E9	409.98	42.26	19.55	12.61	1.42	4.10	1.18	3.47	0.95	1.10
olfactory region, adult	10195-103E6	226.97	56.93	14.14	10.89	1.34	4.97	1.53	2.29	2.29	0.57
optic nerve, donor1	10277-104E7	144.08	62.03	4.00	4.00	2.00	6.00	2.00	6.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	81.10	11.73	5.81	4.56	1.82	1.03	0.46	0.46	0.11	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	53.72	14.01	4.67	7.97	0.00	0.82	0.27	0.41	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	69.42	33.02	4.23	12.70	3.05	1.86	2.20	0.51	0.51	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	82.70	17.21	4.74	1.73	0.35	1.62	0.35	0.35	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	86.72	36.16	6.17	0.88	1.76	1.18	0.29	2.65	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	137.35	33.64	15.88	4.67	0.93	0.93	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	62.35	55.56	12.09	2.97	0.64	1.48	1.06	1.27	0.00	0.42
ovary, adult, pool1	10020-101D2	241.61	34.85	8.39	4.89	6.29	6.55	5.33	3.41	2.80	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.08	30.43	3.12	0.73	0.00	0.37	0.00	0.00	0.00	0.18
pancreas, adult, donor1	10049-101G4	217.29	51.74	12.23	2.82	8.47	15.05	0.94	1.88	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	46.96	7.83	2.24	2.24	0.28	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	69.50	34.07	3.58	7.33	0.34	0.00	1.19	1.36	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	77.99	16.56	4.80	1.99	0.17	0.66	0.17	1.16	0.00	0.66
paracentral gyrus, adult, pool1	10035-101E8	367.37	52.99	17.94	19.68	1.83	6.59	1.83	2.93	2.01	1.65
parietal cortex, adult, donor10258	10373-105G4	193.78	16.88	2.94	27.89	0.73	8.07	0.00	0.00	0.73	5.87
parietal lobe - adult, donor10196	10171-103B9	248.29	48.91	11.29	13.17	0.94	4.70	0.94	0.00	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	316.68	59.86	15.11	13.40	2.85	7.13	1.71	1.71	0.29	2.28
parietal lobe, adult, pool1	10034-101E7	329.04	48.91	18.24	20.27	1.41	6.70	0.70	2.38	1.15	1.32
parietal lobe, fetal, donor1	10072-101I9	318.11	286.10	33.94	13.58	3.88	4.85	6.79	2.91	1.94	2.91
parietal lobe, newborn, donor10223	10356-105E5	179.08	37.01	4.86	19.81	0.37	2.62	1.87	2.62	0.00	0.75
parotid gland, adult	10199-103F1	361.37	48.72	22.82	15.42	3.08	16.65	6.17	2.47	0.62	2.47
penis, adult	10200-103F2	256.20	38.13	8.06	25.24	2.15	10.74	10.21	3.22	2.15	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	68.05	17.29	5.02	0.74	1.67	0.19	0.74	0.56	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	83.77	114.81	12.38	3.93	2.33	1.46	1.17	2.77	0.44	1.75
pineal gland - adult, donor10196	10179-103C8	226.40	66.44	12.26	1.94	6.45	3.87	1.94	3.23	0.65	3.87
pineal gland, adult, donor10252	10160-103A7	316.83	48.56	14.21	2.37	1.78	10.66	1.18	10.66	0.59	2.37
pineal gland, adult, donor10258	10377-105G8	232.02	29.47	6.90	4.39	0.63	6.90	0.00	4.39	0.63	3.76
pituitary gland - adult, donor10196	10180-103C9	195.28	40.47	8.09	1.01	7.08	4.05	1.01	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	263.20	41.17	14.07	6.78	1.56	7.82	1.56	4.17	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	250.27	23.83	4.26	5.96	1.70	6.81	0.85	5.11	0.00	0.85
placenta, adult, pool1	10021-101D3	311.65	33.22	9.68	14.08	4.73	2.80	3.01	2.58	1.83	2.80
plasma cell leukemia cell line:ARH-77	10840-111E3	93.49	44.23	6.89	10.20	0.66	1.06	1.99	0.13	0.13	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	96.96	35.49	10.89	1.71	1.09	2.49	0.47	2.02	0.16	0.16
pons, adult, pool1	10033-101E6	307.43	33.48	9.30	18.50	2.75	13.00	1.72	5.16	1.98	2.84
postcentral gyrus, adult, pool1	10032-101E5	431.78	54.14	18.39	23.19	0.96	6.19	2.18	3.66	1.31	1.22
promyelocytes/myelocytes PMC, donor1	12132-128D8	33.46	18.82	4.18	0.00	0.00	0.00	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	66.10	22.03	5.51	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	35.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	122.21	26.36	7.43	15.15	0.29	1.02	0.87	1.46	0.00	1.89
prostate cancer cell line:PC-3	10439-106E7	83.85	92.20	8.71	1.82	4.17	0.91	1.09	3.99	1.45	0.18
prostate, adult, pool1	10022-101D4	262.73	43.99	15.05	4.81	10.61	3.26	4.08	4.99	3.63	0.45
putamen, adult, donor10196	10176-103C5	202.07	60.20	11.09	39.42	1.89	4.72	1.42	2.60	1.18	2.60
putamen, adult, donor10252	10152-102I8	317.64	29.41	21.57	41.18	3.92	11.76	1.96	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	130.04	19.67	7.65	24.04	2.19	1.09	2.19	0.00	1.09	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	217.69	32.86	12.08	46.39	0.97	5.32	1.21	2.17	0.72	4.83
putamen, newborn, donor10223	10365-105F5	76.47	11.99	1.50	39.73	0.75	0.75	3.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	38.11	11.93	3.78	0.29	0.00	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	126.58	321.32	26.43	1.39	16.69	0.00	1.39	1.39	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	114.27	26.29	8.69	9.96	2.33	1.06	0.85	2.97	0.42	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	38.52	10.36	3.31	0.00	1.24	0.00	0.83	2.07	0.00	0.41
retina, adult, pool1	10030-101E3	302.27	58.75	15.41	2.78	5.96	4.47	1.89	8.35	2.58	1.29
retinoblastoma cell line:Y79	10475-106I7	302.93	61.83	15.33	4.68	7.27	1.30	1.82	3.38	2.60	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	191.06	198.93	19.67	12.05	55.45	1.35	7.75	2.34	10.57	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	115.57	77.89	14.34	1.41	0.28	0.28	1.12	1.69	0.00	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	116.71	80.33	17.43	0.00	8.34	0.76	1.52	9.09	0.00	0.76
salivary acinar cells, donor1	11771-123I7	87.40	29.62	5.34	2.10	3.72	1.29	0.81	1.62	0.32	0.49
salivary acinar cells, donor2	11772-123I8	104.78	22.72	6.20	1.24	2.07	2.34	1.38	0.55	0.14	0.41
salivary acinar cells, donor3	11773-123I9	114.53	41.05	11.25	1.32	4.63	1.32	0.00	1.32	1.32	0.00
salivary gland, adult, pool1	10093-102C3	439.83	22.31	20.02	10.87	2.86	6.29	0.57	2.29	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	74.28	12.39	2.61	2.19	2.95	0.76	0.59	2.11	0.93	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	74.53	22.92	4.00	1.88	4.47	0.24	1.29	2.47	1.06	0.12
seminal vesicle, adult	10201-103F3	275.12	54.49	12.70	1.59	10.05	7.41	1.59	3.70	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	85.02	21.13	3.40	1.21	0.73	0.73	1.70	1.21	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	127.83	20.63	7.30	6.79	0.50	2.77	3.27	2.01	0.00	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	101.36	19.07	2.01	23.08	1.00	4.01	2.01	3.01	0.00	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.33	2.15	0.67	1.34	0.00	0.13	0.27	0.00	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	103.01	16.58	2.32	6.85	0.33	5.08	0.66	0.11	0.00	1.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	109.80	20.13	6.19	3.23	2.45	3.61	1.55	0.65	1.03	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	102.14	34.76	7.09	14.19	2.13	18.44	1.42	1.42	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	481.79	21.47	7.92	31.30	0.96	9.12	3.72	0.84	0.36	1.32
skeletal muscle, fetal, donor1	10066-101I3	148.74	228.14	16.08	3.02	3.02	2.01	4.02	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	122.13	108.56	20.36	0.00	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	130.66	105.41	19.57	13.26	2.52	8.21	1.26	1.26	0.63	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	124.40	238.14	36.35	4.67	2.67	2.33	2.00	2.33	0.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	207.72	61.15	5.04	3.47	0.00	0.00	2.21	0.95	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	58.40	21.20	6.36	1.93	5.01	0.58	1.73	7.52	0.39	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	66.43	49.78	7.75	1.65	0.66	0.49	0.33	0.49	0.16	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	86.70	22.68	3.70	0.32	4.99	0.00	1.13	1.29	2.09	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	152.32	102.86	7.85	0.22	1.09	1.09	1.96	2.83	0.00	0.22
small intestine, adult, pool1	10024-101D6	190.75	27.35	9.08	7.17	3.11	20.42	3.11	1.91	0.48	5.49
small intestine, fetal, donor1	10064-101I1	136.36	114.49	15.48	5.90	3.69	6.63	1.72	1.72	0.98	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	115.40	153.87	7.69	6.15	4.62	2.05	11.80	2.56	4.10	5.13
smooth muscle, adult, pool1	10048-101G3	264.92	68.75	13.44	12.92	15.51	3.88	2.07	2.07	2.33	1.29
somatostatinoma cell line:QGP-1	10781-110G7	183.59	248.72	13.67	0.54	4.02	1.61	0.54	6.70	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	121.81	89.24	9.18	13.08	4.36	6.88	0.69	2.29	2.06	2.98
spinal cord, adult, donor10252	10159-103A6	119.86	37.85	10.65	6.31	1.97	3.15	1.58	1.58	0.39	1.97
spinal cord, adult, donor10258	10369-105F9	96.16	7.61	0.00	5.53	2.08	4.84	0.00	4.15	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	204.29	141.48	28.66	9.15	2.44	9.15	3.66	1.83	0.00	2.44
spinal cord, newborn, donor10223	10359-105E8	103.78	16.53	2.30	8.73	0.00	5.05	1.84	0.46	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	82.14	71.84	12.84	2.69	3.73	2.09	0.15	2.69	0.30	0.00
spleen, adult, pool1	10025-101D7	131.61	72.14	7.49	6.17	6.50	6.72	3.08	1.76	3.74	2.86
spleen, fetal, pool1	10044-101F8	122.20	77.63	6.28	5.88	10.49	4.93	3.97	1.99	5.09	3.02
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	92.95	13.66	5.38	0.52	0.72	0.10	0.41	0.41	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	52.60	13.48	4.37	0.00	0.00	0.00	0.19	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	114.62	17.82	6.29	6.29	0.70	3.49	1.05	0.35	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	87.57	24.24	0.78	0.39	0.00	0.78	0.78	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	98.49	9.23	4.28	1.80	0.00	1.24	0.34	0.00	0.00	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	83.87	26.26	8.47	0.00	0.85	0.00	0.85	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	115.08	20.31	7.62	3.81	0.00	0.42	0.00	0.85	0.00	0.42
stomach, fetal, donor1	10062-101H8	144.18	245.63	28.84	3.20	6.41	6.41	0.00	2.14	0.00	2.14
submaxillary gland, adult	10202-103F4	288.83	59.25	13.67	1.71	7.98	2.85	5.13	6.27	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	119.85	40.09	5.61	6.02	1.66	6.23	1.25	3.53	0.42	2.91
substantia nigra, adult, donor10258	10371-105G2	207.42	13.45	5.69	8.79	1.55	9.83	0.52	1.55	1.55	3.62
substantia nigra, newborn, donor10223	10358-105E7	101.04	29.68	3.53	18.37	0.71	11.31	2.12	0.71	0.71	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	170.34	92.85	25.91	3.90	6.19	2.06	1.60	6.19	0.92	0.00
temporal lobe, adult, pool1	10031-101E4	398.42	60.78	21.70	17.63	1.27	8.56	2.12	3.31	1.44	1.36
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	280.63	381.06	38.46	17.81	2.14	2.85	4.27	1.42	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	208.78	85.27	10.11	15.38	1.76	1.76	7.47	0.00	0.00	0.88
tenocyte, donor1	11763-123H8	84.83	41.54	11.87	5.93	3.49	4.89	3.14	2.79	0.00	0.35
tenocyte, donor2	11765-123I1	64.47	27.47	8.39	3.05	3.05	1.53	3.05	1.53	0.38	0.00
tenocyte, donor3	11768-123I4	77.10	28.91	7.41	0.74	2.22	0.74	0.74	2.22	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	22.26	12.41	2.55	3.57	0.00	0.00	0.00	0.17	0.00	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	33.76	61.81	6.63	1.08	0.15	0.31	1.85	0.62	0.00	0.77
teratocarcinoma cell line:PA-1	10807-111A6	8.99	20.46	4.18	0.15	0.00	0.00	0.46	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.41	16.63	4.44	4.44	0.13	0.25	0.13	0.13	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.91	5.67	2.27	1.13	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	72.74	20.29	3.49	21.27	0.00	1.64	0.76	0.44	0.33	2.51
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	35.18	6.84	3.58	8.47	0.00	0.65	1.30	0.00	0.00	1.30
testis, adult, pool1	10026-101D8	202.50	26.95	10.95	2.79	10.95	3.22	4.19	2.15	6.33	0.97
testis, adult, pool2	10096-102C6	134.87	20.75	2.26	1.35	12.18	7.67	5.41	2.71	5.41	0.45
thalamus - adult, donor10196	10168-103B6	154.56	50.78	4.42	8.83	1.10	5.52	1.10	2.21	0.00	1.10
thalamus, adult, donor10252	10154-103A1	156.13	40.48	7.97	12.50	2.81	5.94	1.09	3.91	1.56	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	344.87	15.40	4.62	6.16	1.54	6.16	0.00	0.00	3.08	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	214.76	65.71	8.89	14.99	2.96	14.16	3.62	2.47	0.49	4.61
thalamus, newborn, donor10223	10366-105F6	146.13	35.67	3.45	27.04	1.15	12.66	7.48	0.00	0.58	6.90
throat, adult	10209-103G2	288.87	37.45	7.99	19.97	3.75	5.49	6.24	1.50	0.75	0.25
throat, fetal, donor1	10061-101H7	140.47	187.39	24.38	9.14	6.70	10.66	2.13	1.52	0.61	3.35
thymic carcinoma cell line:Ty-82	10803-111A2	74.72	62.40	14.51	0.40	2.19	0.00	0.99	1.39	0.00	0.20
thymus, adult, pool1	10027-101D9	145.25	196.94	14.81	16.20	24.95	0.70	4.18	1.59	3.78	1.59
thymus, fetal, pool1	10043-101F7	111.18	120.63	9.25	12.26	21.61	0.73	2.29	1.14	4.36	2.29
thyroid carcinoma cell line:KHM-5M	10776-110G2	73.53	19.81	4.52	0.80	0.00	0.40	0.80	0.53	0.00	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	106.03	95.97	6.29	7.40	11.31	1.82	1.12	2.24	2.10	0.14
thyroid, adult, pool1	10028-101E1	356.74	41.24	24.82	9.05	3.17	11.57	2.71	4.95	1.77	1.68
thyroid, fetal, donor1	10060-101H6	235.71	170.85	23.73	14.77	4.48	28.48	1.58	2.64	2.11	3.95
tongue epidermis (fungiform papillae), donor1	10288-104F9	98.55	95.47	24.64	12.32	3.08	12.32	3.08	0.00	0.00	3.08
tongue, adult	10203-103F5	210.48	27.44	4.65	20.23	2.56	8.37	6.98	1.40	1.40	0.23
tongue, fetal, donor1	10059-101H5	254.58	123.75	16.55	7.09	3.55	12.61	2.76	2.76	0.39	1.58
tonsil, adult, pool1	10047-101G2	202.15	75.53	12.02	11.22	9.52	2.70	1.80	1.00	3.01	1.70
trachea, adult, pool1	10029-101E2	169.90	45.64	11.04	5.97	2.94	4.74	2.78	2.78	1.39	1.15
trachea, fetal, donor1	10058-101H4	143.49	169.27	16.93	9.23	10.77	10.00	3.46	1.54	1.15	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	65.19	63.77	6.02	3.54	7.09	2.48	1.06	1.77	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	161.90	50.76	6.69	3.75	1.72	1.22	0.91	2.43	1.11	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	107.33	18.49	5.17	7.52	2.19	1.25	1.10	1.88	0.63	0.47
tridermal teratoma cell line:HGRT	10694-109G1	116.05	104.64	30.44	0.00	7.61	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	96.67	115.89	7.87	1.78	8.63	1.61	2.88	1.44	3.64	0.51
umbilical cord, fetal, donor1	10057-101H3	114.76	68.85	16.69	6.26	0.00	6.26	6.26	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	216.36	27.30	8.70	3.24	13.48	2.39	3.41	2.90	5.12	0.51
uterus, fetal, donor1	10055-101H1	99.31	191.46	25.08	1.02	7.68	3.07	2.05	2.05	0.00	1.54
vagina, adult	10204-103F6	222.29	54.28	11.63	7.75	7.11	5.17	1.94	3.88	1.29	0.00
vein, adult	10191-103E2	111.35	80.01	4.82	1.32	12.49	1.75	4.82	2.19	2.85	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	95.33	37.39	6.68	7.74	1.34	1.07	1.07	0.27	1.07	0.80